Automated drug delivery device

Abstract

This utility model discloses an automatic drug delivery device, relating to the field of reagent injection technology. The automatic drug delivery device includes: a shielded housing forming a first shielded cavity; and a reagent injection assembly, at least a portion of which is disposed within the first shielded cavity. The reagent injection assembly is adapted to connect to a reagent bottle and an infusion device, serving to connect the reagent bottle and the infusion device, and also driving the reagent within the reagent bottle to flow along the reagent injection assembly. This simplifies the injection process and reduces injection costs. The fact that at least a portion of the reagent injection assembly is disposed within the first shielded cavity provides shielding, thereby reducing the radiation hazards of the reagent within the assembly to staff and patients, and effectively protecting their safety.

Description

[0001] Cross-reference to related applications

[0002] This application is based on and claims priority to Chinese Patent Application No. 202410648770.0, filed on May 23, 2024, the entire contents of which are incorporated herein by reference. Technical Field

[0003] This utility model relates to the field of reagent injection technology, and in particular to an automatic drug delivery device. Background Technology

[0004] Among related technologies, drugs for tumor diagnosis and treatment are developing rapidly, with radiopharmaceuticals emerging in particular. Radiopharmaceuticals are a special class of drugs that contain radioactive nuclides and are used for medical diagnosis and treatment. Radiopharmaceuticals pose radiation hazards to workers and pose a risk of environmental exposure. Existing injection systems require workers to connect syringes to vials, making it difficult to avoid radiation hazards. Utility Model Content

[0005] The present invention aims to solve at least one of the technical problems existing in the prior art. Therefore, one objective of the present invention is to provide an automated drug delivery device that simplifies injection procedures, reduces injection costs, and minimizes the radiation hazards of reagents to staff and patients, thereby effectively protecting the personal safety of staff and patients.

[0006] An automatic drug delivery device according to an embodiment of the present invention includes: a shielded box having a first shielded cavity; a reagent injection assembly having at least a portion disposed within the first shielded cavity, the reagent injection assembly being adapted to connect to a reagent bottle and an infusion fitting, the reagent injection assembly being used to connect the reagent bottle and the infusion fitting, and the reagent injection assembly being used to drive the reagent in the reagent bottle to flow along the reagent injection assembly.

[0007] The automated drug delivery device according to an embodiment of this utility model uses a shielded housing to carry the entire device. By placing at least a portion of the reagent injection assembly within a first shielded cavity, the reagent injection assembly is shielded, thereby reducing the radiation hazard to workers and patients from the reagent within the assembly. Furthermore, the reagent injection assembly connects the reagent bottle and the infusion unit, and also drives the reagent in the bottle to flow along the assembly to the infusion unit, enabling automated reagent dispensing, transfer, and injection. This significantly reduces contact between workers and the reagent during injection, further minimizing radiation hazard and effectively protecting the safety of both workers and patients. On the other hand, the automated drug delivery device allows for sequential injection of multiple patients, improving injection efficiency and reducing injection costs.

[0008] According to some embodiments of this utility model, the shielding box is movable.

[0009] According to some embodiments of this utility model, the infusion device is an indwelling needle or an intravenous infusion needle.

[0010] According to some embodiments of the present invention, the reagent injection assembly includes: a reagent delivery device adapted to be connected to a reagent bottle and an infusion fitting, the reagent delivery device being used to connect the reagent bottle and the infusion fitting; and a reagent injection device disposed within a first shielded cavity, the reagent injection device cooperating with the reagent delivery device to drive the reagent in the reagent bottle to flow along the reagent delivery device.

[0011] According to some embodiments of the present invention, the reagent injection device is provided with multiple drive pumps, and the reagent delivery device includes a manifold and multiple delivery lines. Each delivery line is adapted to be connected to a corresponding reagent bottle. The manifold and multiple delivery lines are connected to each other so that the delivery lines connect the manifold and the corresponding reagent bottle. Each delivery line is cooperated with a corresponding drive pump so that the reagent in the corresponding reagent bottle flows into the manifold or another delivery line. The manifold is adapted to be connected to an infusion fitting.

[0012] According to some embodiments of the present invention, the reagent delivery device further includes: a manifold block, a manifold cavity formed therein, the manifold block being connected to a manifold pipeline and multiple delivery pipelines, the manifold cavity being connected to the manifold pipeline and multiple delivery pipelines, and the manifold block being fixed to the reagent injection device.

[0013] According to some embodiments of the present invention, the shielding box has a top cover, which is the top wall of the first shielding cavity. The top cover is rotatably or slidably disposed on the shielding box to open or close the first shielding cavity.

[0014] According to some embodiments of the present invention, the automatic drug delivery device further includes a locking structure, which is disposed in the shielded housing and is used to lock or unlock the top cover.

[0015] According to some embodiments of this utility model, the locking structure is constructed as a mechanical locking structure or an electric locking structure.

[0016] According to some embodiments of the present invention, the top cover has a first shielding cover, and the shielding box has an operating hole communicating with the first shielding cavity. The first shielding cover is used to open or close the operating hole.

[0017] According to some embodiments of the present invention, there are multiple operating holes and multiple first shielding covers, and the multiple operating holes and multiple first shielding covers correspond one-to-one.

[0018] According to some embodiments of the present invention, the automatic drug delivery device further includes an activity detection device, which is used to measure the activity of the reagent before and after injection.

[0019] According to some embodiments of the present invention, the activity detection device is disposed in the first shielding cavity or is fixedly disposed in the first shielding cavity, and the activity detection device is used to place the reagent delivery device and / or the corresponding reagent bottle.

[0020] According to some embodiments of the present invention, the automatic drug delivery device further includes: a fixing frame, the fixing frame being located inside a first shielding cavity, the fixing frame being fixed to a shielding box, the activity detection device being used to place a reagent delivery device and / or a corresponding reagent bottle, the fixing frame being covered at the open end of the activity detection device, the fixing frame having a first through hole corresponding to the open end of the activity detection device, the reagent delivery device and / or the corresponding reagent bottle being placed into the activity detection device through the first through hole or taken out of the activity detection device.

[0021] According to some embodiments of the present invention, the automatic drug delivery device further includes: an activity display screen, which is disposed in a shielded box, and the activity display screen is located outside or inside the shielded box, and the activity display screen is communicatively connected to an activity detection device.

[0022] According to some embodiments of the present invention, the automatic drug delivery device further includes: a waste shielding container, wherein the shielding box body also forms a second shielding cavity communicating with the first shielding cavity, and the waste shielding container is disposed in the second shielding cavity.

[0023] According to some embodiments of the present invention, the automatic drug delivery device further includes: a second shielding cover, wherein the shielding box has a communication port connecting the first shielding cavity and the second shielding cavity, and the second shielding cover is used to open or close the communication port.

[0024] According to some embodiments of the present invention, the second shielding cavity is located below and adjacent to the first shielding cavity, the bottom wall of the first shielding cavity has a communication opening, and the second shielding cover is located inside the first shielding cavity.

[0025] According to some embodiments of the present invention, the shielding box has a shielding door, and the second shielding cavity has a pick-up and put-out opening, and the shielding door is used to open or close the pick-up and put-out opening.

[0026] According to some embodiments of the present invention, the shielding box has an observation port corresponding to the first shielding cavity, and the observation port is provided with shielding glass.

[0027] According to some embodiments of the present invention, the automatic drug delivery device further includes: a shielding container, which is adapted to be placed in a first shielding cavity and is used to store corresponding reagent bottles.

[0028] According to some embodiments of the present invention, there are multiple shielding containers, and all of the multiple shielding containers are suitable for placement inside the first shielding cavity.

[0029] According to some embodiments of the present invention, the automatic drug delivery device further includes a controller, which is communicatively connected to the reagent injection device and configured to control the operation of the reagent injection device.

[0030] According to some embodiments of the present invention, a storage slot is formed on the outside of the shielding box, and the storage slot is used to place the controller.

[0031] According to some embodiments of the present invention, the automatic drug delivery device further includes: an operating table, which is fixedly disposed in the shielded box and located outside and on one side of the first shielded cavity. The top wall of the operating table has a storage trough that is inclined along the height direction of the automatic drug delivery device.

[0032] According to some embodiments of the present invention, the automatic drug delivery device further includes an anti-loss structure, which is connected to both the controller and the shielding housing.

[0033] According to some embodiments of the present invention, the automatic drug delivery device further includes: an emergency stop operation key and an operation table. The operation table is fixed in the shielded box and is located outside the first shielded cavity and on one side of the first shielded cavity. The top wall of the operation table is provided with an emergency stop operation key, which is configured to disconnect the reagent injection device from the power supply.

[0034] According to some embodiments of the present invention, the automatic drug delivery device further includes: a power operation key and an operation table. The operation table is fixed in the shielded box and is located outside the first shielded cavity and on one side of the first shielded cavity. The top wall of the operation table is provided with a power operation key, which is configured to control the automatic drug delivery device to power on or off.

[0035] According to some embodiments of the present invention, the automatic drug delivery device further includes: a disinfection device disposed within a first shielding cavity, the disinfection device being selectively turned on or off.

[0036] According to some embodiments of the present invention, the disinfection device is fixed to the side wall of the first shielding cavity.

[0037] According to some embodiments of the present invention, the automatic drug delivery device further includes: a disinfection operation key, which is configured to disconnect or connect the disinfection device to the power supply.

[0038] According to some embodiments of the present invention, the automatic drug delivery device further includes: an operating table, which is fixed to the shielded box and located outside and on one side of the first shielded cavity, and the top wall of the operating table is provided with a disinfection operation button.

[0039] According to some embodiments of the present invention, the automatic drug delivery device further includes: a table, which is disposed on the outer surface of the shielded box and is used to place objects.

[0040] According to some embodiments of the present invention, the tabletop is movably disposed in the shielding box, and the tabletop has a first position and a second position. When the tabletop is in the first position, the tabletop is parallel to the horizontal plane, and when the tabletop is in the second position, the tabletop is perpendicular to the horizontal plane.

[0041] According to some embodiments of the present invention, the automatic drug delivery device further includes: a support structure connected between the table and the shielding box, wherein the support structure supports the table when the table is in the first position.

[0042] According to some embodiments of the present invention, the tabletop has a first end and a second end opposite to each other. The first end is rotatably disposed in the shielding box. An installation beam is formed on the lower surface of the tabletop. The installation beam has a strip-shaped limiting hole. The strip-shaped limiting hole extends along the arrangement direction of the first end and the second end. The support structure includes a support rod. One end of the support rod is rotatably connected to the shielding box. The other end of the support rod is assembled in the strip-shaped limiting hole and is movable along the strip-shaped limiting hole.

[0043] According to some embodiments of the present invention, a second through hole communicating with the first shielding cavity is formed on the side wall of the first shielding cavity, and the reagent injection assembly passes through the second through hole.

[0044] According to some embodiments of this utility model, the shielding box is connected to casters.

[0045] According to some embodiments of this utility model, the shielding box is provided with a handle.

[0046] According to some embodiments of the present invention, a plurality of fixing seats are fixed on the outer surface of the reagent injection device, and the plurality of fixing seats are respectively used for installing the manifold and the plurality of delivery lines.

[0047] According to some embodiments of the present invention, at least one of the manifold and multiple delivery pipelines is provided with a bubble detection element, which is fixed to the reagent injection device.

[0048] According to some embodiments of the present invention, the manifold is provided with a flow detection element, which is fixed to the reagent injection device.

[0049] According to some embodiments of the present invention, the manifold is provided with an air filter.

[0050] According to some embodiments of the present invention, the automatic drug delivery device further includes: a support base, the support base being fixedly disposed within a first shielding cavity, the upper surface of the support base being at least partially an inclined surface, and an air filter being installed on the inclined surface.

[0051] According to some embodiments of the present invention, the automatic drug delivery device further includes: a fixing frame, the fixing frame being located inside the first shielding cavity and fixed to the shielding box, and a support base being fixed to the fixing frame.

[0052] According to some embodiments of the present invention, the automatic drug delivery device further includes: a fixing base, and multiple fixing bases are fixed on the surface of the fixing frame, the multiple fixing bases being used to install the manifold and multiple delivery pipelines respectively.

[0053] According to some embodiments of the present invention, at least one of the manifold and multiple delivery lines is constructed as a flexible hose.

[0054] According to some embodiments of the present invention, the reagent injection assembly further includes: a liquid taking device, both the liquid taking device and the reagent delivery device are disposed in the first shielding cavity, the liquid taking device is used to place the corresponding reagent bottle, and the liquid taking device cooperates with the reagent delivery device to drive the reagent delivery device to insert or pull out the corresponding reagent bottle.

[0055] According to some embodiments of the present invention, the reagent delivery device has a needle, the liquid dispensing device has a moving part and a placement groove, the moving part and the placement groove are opposite to and spaced apart, the placement groove is used to store the corresponding reagent bottle, the needle is detachably assembled to the moving part, and the moving part moves toward or away from the placement groove to drive the needle to insert or pull out the corresponding reagent bottle.

[0056] According to some embodiments of the present invention, the controller is communicatively connected to the liquid dispensing device, and the controller is configured to control the operation of the liquid dispensing device.

[0057] According to some embodiments of the present invention, the automatic drug delivery device further includes: a fixing frame, which is located in the first shielding cavity and fixed to the shielding box, and a portion of at least one of the liquid dispensing device, the reagent injection device and the reagent delivery device is fixedly assembled to the fixing frame.

[0058] According to some embodiments of the present invention, the automatic drug delivery device further includes an alarm device for issuing alarm information.

[0059] Additional aspects and advantages of this invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. Attached Figure Description

[0060] The above and / or additional aspects and advantages of this utility model will become apparent and readily understood from the description of the embodiments taken in conjunction with the following drawings, in which:

[0061] Figure 1 This is a schematic diagram of the external structure of the automatic drug delivery device according to the first embodiment of this utility model;

[0062] Figure 2 This is a schematic diagram of the internal structure of the automatic drug delivery device according to the first embodiment of this utility model;

[0063] Figure 3 This is a schematic diagram of the structure of the reagent injection device according to an embodiment of the present invention;

[0064] Figure 4 This is a schematic diagram of the reagent delivery device according to an embodiment of the present invention;

[0065] Figure 5 This is a schematic diagram of the external structure of the automatic drug delivery device according to the second embodiment of this utility model;

[0066] Figure 6 This is a schematic diagram of the internal structure of the automatic drug delivery device according to the second embodiment of this utility model;

[0067] Figure 7 This is a schematic diagram of the automatic drug delivery device according to the second embodiment of the present invention from another perspective;

[0068] Figure 8 This is a schematic diagram of the external structure of the automatic drug delivery device according to the third embodiment of this utility model;

[0069] Figure 9 This is a schematic diagram of the internal structure of the automatic drug delivery device according to the third embodiment of this utility model;

[0070] Figure 10 yes Figure 9 Enlarged diagram of point A in the middle.

[0071] Figure label:

[0072] Automated drug delivery device 300;

[0073] Shielding enclosure 301; First shielding cavity 302; Shielding tank 303; Liquid extraction device 304; Moving part 305; Placement slot 306; First shielding cover 307; Operating hole 308; Activity detection device 309; Activity display screen 310; Waste shielding container 311; Second shielding cavity 312; Second shielding cover 313; Connecting port 314; Shielding door 315; Take-out port 316; Observation port 317; Controller 318; Emergency stop button 319; Casters 320; Handle 321; Mounting cavity 322; Storage slot 323; Handle 324; Hook 325;

[0074] 200 reagent injection devices;

[0075] 202 outer casing; 203 mounting base;

[0076] Reagent delivery device 100;

[0077] 10. Manifold; 13. Manifold block; 14. Manifold cavity; 15. Connector;

[0078] Delivery pipeline 20; drive pump 23;

[0079] 30 reagent bottles;

[0080] Flow detection element 40; bubble detection element 41; pin 42; air filter 43; limit part 44;

[0081] Reagent injection assembly 500;

[0082] Top cover 51; locking structure 52; fixing bracket 53; opening and closing cover 54; first through hole 55; operating table 56; power operation button 57; disinfection device 58; disinfection operation button 59; table board 60; support structure 61; support rod 62; mounting beam 63; strip-shaped limiting hole 64; second through hole 65; saline bag 66; bracket base 68; mounting slope 681; alarm device 69. Detailed Implementation

[0083] The embodiments of this utility model are described in detail below. Examples of these embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals denote the same or similar elements or elements having the same or similar functions throughout. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain this utility model, and should not be construed as limiting this utility model.

[0084] The following is for reference. Figures 1-10The automatic drug delivery device 300 according to an embodiment of the present invention is described, wherein the reagent can be a liquid reagent or a solid reagent. The liquid reagent can be a liquid drug or other chemical liquid reagent, and the solid reagent can be a powdered drug. This application takes a drug as an example for description. The drug can be a radiopharmaceutical, physiological saline, etc. Radiopharmaceuticals refer to a special class of drugs containing radionuclides and used for medical diagnosis and treatment. Radiopharmaceuticals can be drugs used for tumor diagnosis and treatment.

[0085] like Figures 1-10 As shown, the automatic drug delivery device 300 according to an embodiment of the present invention includes: a shielded box 301, the shielded box 301 having a first shielded cavity 302; a reagent injection assembly 500, at least a portion of which is disposed within the first shielded cavity 302, the reagent injection assembly 500 being adapted to connect with a reagent bottle 30 and an infusion device, the reagent injection assembly 500 being used to connect the reagent bottle 30 and the infusion device, and the reagent injection assembly 500 being used to drive the reagent in the reagent bottle 30 to flow along the reagent injection assembly 500.

[0086] Typically, the reagent injection assembly 500 is adapted to be connected to the reagent bottle 30 and to infusion fittings on live animals.

[0087] A living animal refers to an organism possessing life characteristics, a multicellular structure, heterotrophic nutrition, and the ability to move. It belongs to the animal kingdom and includes animal bodies and humans, as well as other animal individuals in a state of life activity. This application uses the injection of radiopharmaceuticals into a human as an example for illustration, but it is not limited to this application scenario and can also be used in animal experimental settings.

[0088] In clinical injection scenarios, the reagent injection assembly 500 is adapted to be connected to the reagent bottle 30 and the infusion device on the human body; in animal experiments, the reagent injection assembly 500 is adapted to be connected to the reagent bottle 30 and the infusion device on the animal body.

[0089] Infusion sets refer to various medical devices and tools used to infuse medications or fluids into a patient's body, including but not limited to infusion needles, indwelling needles, injection needles, and needles. The main function of these devices is to infuse medications or fluids into the patient's body through different routes (such as intravenous or subcutaneous) to achieve therapeutic, fluid replenishment, or nutritional support purposes. This application uses an indwelling needle as an example for illustration. After puncturing a vein, the indwelling catheter is left in the blood vessel, and the needle is withdrawn. After the infusion is completed, only the catheter needs to be sealed. The catheter can remain in place for a relatively long time, reducing the harm to the patient from multiple infusions.

[0090] The automatic drug delivery device 300 includes a shielded enclosure 301, which is used to support the automatic drug delivery device 300. The shielded enclosure 301 can be made of shielding material, such as lead plate, iron plate or other shielding material, so that the shielded enclosure 301 can form a first shielding cavity 302. Further, the shielded enclosure 301 can be defined by coating the surface of the lead plate with an alloy material to define the first shielding cavity 302. The first shielding cavity 302 has shielding effectiveness and can play the role of shielding radiation.

[0091] At least a portion of the reagent injection assembly 500 is disposed within the first shielding cavity 302. For example, half of the reagent injection assembly 500 may be disposed within the first shielding cavity 302, or one-third of the reagent injection assembly 500 may be disposed within the first shielding cavity 302, or the entire structure of the reagent injection assembly 500 may be disposed within the first shielding cavity 302. However, this invention is not limited to these provisions, and the reagent injection assembly 500 may also be disposed within the first shielding cavity 302 in other proportions, as long as at least a portion of the reagent injection assembly 500 is disposed within the first shielding cavity 302. As one embodiment of the application, a portion of the reagent injection assembly 500 may be located outside the first shielding cavity 302, and this portion may be connected to the infusion device inside the patient's body. As another embodiment of the application, there may also be an independent conduit for connecting the reagent injection assembly 500 within the first shielding cavity 302 to the infusion device inside the patient's body.

[0092] The reagent injection assembly 500 is adapted to be connected to the reagent bottle 30 via an infusion fitting, thereby enabling the reagent injection assembly 500 to connect the reagent bottle 30 and the infusion fitting. The reagent injection assembly 500 also drives the reagent within the reagent bottle 30 to flow along the reagent injection assembly 500, thus achieving the effect of the reagent within the reagent bottle 30 flowing sequentially from the reagent injection assembly 500 and the infusion fitting into the patient's body (e.g., enabling the sequential flow of radiopharmaceuticals, saline solution, or the flow of saline solution along the reagent injection assembly 500 to expel air from the reagent injection assembly 500). In addition, the reagent injection assembly 500 can also be connected to an infusion device on the animal body, so that the reagent injection assembly 500 is used to connect the reagent bottle 30 and the infusion device, and the reagent injection assembly 500 is also used to drive the reagent in the reagent bottle 30 to flow along the reagent injection assembly 500, thereby realizing the effect of the reagent in the reagent bottle 30 flowing into the animal body sequentially through the reagent injection assembly 500 and the infusion device (for example, the effect of radiopharmaceuticals flowing into the animal body sequentially through the reagent injection assembly 500 and the infusion device, or the effect of physiological saline flowing into the animal body sequentially through the reagent injection assembly 500 and the infusion device, or the effect of physiological saline flowing along the reagent injection assembly 500 to expel air from the reagent injection assembly 500).

[0093] This setup enables automated reagent dispensing, transfer, and injection, significantly reducing staff contact with reagents during injection and thus minimizing radiation hazards to staff, effectively protecting the safety of both staff and patients. Furthermore, the automated drug delivery device 300 can hold multiple reagent bottles 30, allowing for sequential injection of multiple patients or animals, improving injection efficiency and reducing costs.

[0094] It can be noted that the reagent bottle 30 can be a container for holding reagents, such as a bottle or a bag. More specifically, the reagent bottle 30 can be a vial or a saline bag.

[0095] According to some embodiments of the present invention, the shielding box 301 is movable, which makes it convenient for staff to move the shielding box 301 to the patient's bedside for operation, thereby making it convenient for the patient to receive injections.

[0096] According to some embodiments of this utility model, the infusion device can be an indwelling needle or an intravenous infusion needle, which can be reasonably selected according to the actual situation. When only a single injection is needed for the patient, an intravenous infusion needle can be used, and when multiple injections are needed for the patient, an indwelling needle can be used. The indwelling needle can remain in the patient's vein for several days, avoiding the need for repeated punctures, reducing the patient's pain and discomfort, and also reducing the workload of medical staff.

[0097] According to some embodiments of the present invention, such as Figure 3 As shown, the reagent injection assembly 500 includes: a reagent delivery device 100, which is adapted to be connected to the reagent bottle 30 and the infusion device, and is used to connect the reagent bottle 30 and the infusion device; and a reagent injection device 200, which is disposed in the first shielding cavity 302. The reagent injection device 200 cooperates with the reagent delivery device 100 to drive the reagent in the reagent bottle 30 to flow along the reagent delivery device 100.

[0098] The reagent delivery device 100 is adapted to connect with the reagent bottle 30 and the infusion set, and the reagent delivery device 100 is used to connect the reagent bottle 30 and the infusion set so that the reagent in the reagent bottle 30 can be delivered to the infusion set through the reagent delivery device 100 for injection into the patient. The reagent injection device 200 is disposed in the first shielding cavity 302. For example, the reagent injection device 200 and the shielding box 301 can be connected by snap-fit ​​or by bolts. However, this utility model is not limited to these methods. The reagent injection device 200 and the shielding box 301 can also be connected by other methods, as long as the reagent injection device 200 is disposed in the first shielding cavity 302. This design allows the first shielding cavity 302 to both shield the reagent injection device 200 and protect it by covering it, thereby reducing the risk of the reagent injection device 200 being bumped or scratched by external objects and extending its service life. The reagent injection device 200 works in conjunction with the reagent delivery device 100 to drive the reagent in the reagent bottle 30 to flow along the reagent delivery device 100, enabling the delivery of reagents within the device (e.g., radiopharmaceuticals flowing sequentially from the reagent delivery device 100 and the infusion unit to the patient, or saline solution flowing sequentially from the reagent delivery device 100 and the infusion unit to the patient, or saline solution expelling air along the reagent delivery device 100). Therefore, by using the shielded enclosure 301 for the mobile automated drug delivery device 300, it is convenient for staff to move the device to the patient's bedside for operation, thus facilitating patient injection. Multiple reagent bottles 30 can be stored inside the shielded enclosure 301 simultaneously, allowing for sequential injection of multiple patients in one trip, improving injection efficiency and reducing injection costs. By placing both the reagent bottle 30, reagent delivery device 100, and reagent injection device 200 within the first shielded cavity 302, the radiation hazards to staff and patients can be reduced. Furthermore, through the coordinated use of the reagent delivery device 100 and reagent injection device 200, the automated drug delivery device 300 can automatically pick up, transport, and inject reagents, significantly reducing staff contact with reagents during injection, further minimizing radiation hazards to staff, and effectively ensuring the safety of staff and patients.

[0099] According to some embodiments of the present invention, such as Figure 3As shown, the reagent injection device 200 is equipped with multiple drive pumps 23, and the reagent delivery device 100 includes a manifold 10 and multiple delivery lines 20. Each delivery line 20 is adapted to be connected to a corresponding reagent bottle 30. The manifold 10 is connected to the multiple delivery lines 20 so that the delivery line 20 connects the manifold 10 and the corresponding reagent bottle 30. Each delivery line 20 is cooperated with a corresponding drive pump 23 so that the reagent in the corresponding reagent bottle 30 flows into the manifold 10 or another delivery line 20. The manifold 10 is adapted to be connected to an infusion device.

[0100] The reagent injection device 200 can be equipped with multiple drive pumps 23, such as two, three, or four. However, this invention is not limited to this; the reagent injection device 200 can also be equipped with other numbers of drive pumps 23, as long as it has multiple drive pumps 23. The drive pump 23 can be a peristaltic pump, screw pump, or other pump body. This application uses a peristaltic pump as an example for illustration. Peristaltic pumps have sufficient self-priming force, good sealing performance, and high precision, thereby improving the performance of the reagent injection device 200. At the same time, peristaltic pumps are easy to maintain, which can reduce the maintenance cost of the reagent injection device 200.

[0101] The reagent delivery device 100 includes a manifold 10 and multiple delivery lines 20. For example, the reagent delivery device 100 may include two, three, four, or other numbers of delivery lines 20, but this invention is not limited to this. The reagent delivery device 100 may also include other numbers of delivery lines 20, as long as the reagent delivery device 100 includes multiple delivery lines 20. All delivery lines 20 are adapted to communicate with corresponding reagent bottles 30. For example, the delivery lines 20 and reagent bottles 30 can be connected via metal pins 42 to allow the delivery lines 20 to communicate with the reagent bottles 30, thereby enabling the reagents in the reagent bottles 30 to enter the corresponding delivery lines 20. The reagent delivery scheme of the delivery lines 20 can be set and controlled by the software system according to the infusion scheme of different patients, thereby enabling convenient and accurate reagent dispensing without manual dispensing. This avoids waste of reagents due to operational errors during manual dispensing. Furthermore, when the reagents are toxic or radioactive, using the delivery lines 20 to dispense the reagents can also prevent the toxic or radioactive reagents from harming the health of the staff.

[0102] The manifold 10 and multiple delivery lines 20 can be integrally formed, or the manifold 10 and multiple delivery lines 20 can be assembled through connectors 15. For example, the manifold 10 and multiple delivery lines 20 can also be assembled through Luer connectors so that the manifold 10 and multiple delivery lines 20 are all connected. This allows the delivery lines 20 to connect the manifold 10 and the corresponding reagent bottles 30, so that the reagents in each reagent bottle 30 can enter the manifold 10 through the corresponding delivery lines 20. This enables convenient and accurate reagent dispensing without manual dispensing, avoiding waste of reagents due to operational errors during manual dispensing. Furthermore, when the reagents are toxic or radioactive, using the delivery lines 20 and manifold 10 together to dispense the reagents can also prevent toxic or radioactive reagents from harming the health of workers. This application uses the example of the manifold 10 and multiple delivery pipes 20 being integrally formed. The integrally formed pipes can reduce the risk of leakage and contamination of the drug solution caused by passing through multiple components, thereby improving the safety and reliability of the reagent delivery device 100 and effectively protecting the safety of patients.

[0103] like Figure 4 As shown, each delivery pipeline 20 may be provided with a limiting part 44. When each delivery pipeline 20 is in cooperation with the corresponding drive pump 23, the limiting part 44 can limit the delivery pipeline 20, thereby reducing the risk of the delivery pipeline 20 falling off the drive pump 23, and thus improving the safety and reliability of the reagent delivery device 100.

[0104] Each delivery line 20 is coupled to a corresponding drive pump 23 to allow the reagent in the corresponding reagent bottle 30 to flow into the manifold 10 or another delivery line 20. The dosage of the reagent delivered by the delivery line 20 can be set via software system settings according to different patients' infusion protocols, controlling the operation of the drive pump 23. The drive pump 23 then pumps the reagent from the corresponding reagent bottle 30 into the corresponding delivery line 20, where the reagent flows into the manifold 10 or another delivery line 20. The manifold 10 is adapted to connect to an infusion device, for example: Figure 4 As shown, the manifold 10 and the infusion set can be connected and communicated via a connector 15, which can be a Luer connector. When the infusion set is inserted into the patient's body, the reagent can be delivered to the patient's body through the infusion set to complete the infusion. Therefore, the reagent dispensing process of the reagent injection device 200 of this application is precise, convenient, and efficient. It not only eliminates the cumbersome steps of manual reagent dispensing but also avoids reagent waste caused by human error and prevents toxic or radioactive reagents from harming the health of staff.

[0105] As one embodiment of this application, there can be two delivery lines 20. One delivery line 20 delivers radiopharmaceuticals, and the other delivery line 20 delivers saline solution. Saline solution can be delivered first through the corresponding delivery line 20 to purge air and bubbles from the line. Then, radiopharmaceuticals are delivered to the patient through the corresponding delivery line 20. After the radiopharmaceutical delivery is completed, saline solution is delivered to the patient again through the corresponding delivery line 20 to flush the radiopharmaceuticals in the manifold 10, so that any residual radiopharmaceuticals in the manifold 10 are delivered to the patient. The injection is stopped immediately after the residual radiopharmaceuticals are delivered to the patient. This can maximize the accuracy of drug injection dosage and drug activity, thereby improving the injection accuracy of the automatic drug delivery device 300.

[0106] Furthermore, in the radiopharmaceutical delivery scenario, four stages are required: the first stage of degassing, the second stage of degassing, the delivery stage, and the drug exhaustion stage. In the first stage of degassing, the manifold 10 is not connected to the patient. The drive pumps 23 (usually peristaltic pumps) on both the radiopharmaceutical delivery line 20 and the saline delivery line 20 are simultaneously activated, controlling the flow of saline from the saline delivery line 20 to the radiopharmaceutical delivery line 20, thus purging air bubbles from each delivery line 20. In the second stage of degassing, the manifold 10 is not connected to the patient. The corresponding drive pump 23 (usually a peristaltic pump) on the radiopharmaceutical delivery line 20 stops working, while the corresponding drive pump 23 (usually a peristaltic pump) on the saline delivery line 20 is activated, controlling the flow of saline to the manifold 10, purging air bubbles from the manifold 10. During the drug administration phase, the manifold 10 is connected to the patient. The corresponding drive pump 23 (usually a peristaltic pump) on the saline delivery line 20 stops working, while the corresponding drive pump 23 (usually a peristaltic pump) on the radiopharmaceutical delivery line 20 starts, controlling the flow of radiopharmaceutical to the manifold 10 and into the patient. During the drug exhaustion phase, the corresponding drive pump 23 (usually a peristaltic pump) on the radiopharmaceutical delivery line 20 stops working, while the corresponding drive pump 23 (usually a peristaltic pump) on the saline delivery line 20 starts, controlling the flow of saline to the manifold 10 to deliver any remaining drug in the manifold 10 into the patient. Injection is stopped immediately after the remaining radiopharmaceutical is delivered into the patient. This maximizes the accuracy of drug dosage and drug activity, thereby improving the injection accuracy of the automated drug delivery device 300.

[0107] According to some embodiments of the present invention, such as Figure 3As shown, the reagent delivery device 100 further includes: a manifold 13, a manifold cavity 14 formed in the manifold 13, the manifold 13 is connected to the manifold 10 and multiple delivery pipelines 20, the manifold cavity 14 is connected to the manifold 10 and multiple delivery pipelines 20, and the manifold 13 is fixed to the reagent injection device 200.

[0108] The reagent delivery device 100 may include a manifold 13, which can be fixed to the reagent injection device 200. For example, the manifold 13 and the reagent injection device 200 can be fixedly connected by snap-fit ​​or by adhesive bonding. However, this invention is not limited to these methods; the manifold 13 and the reagent injection device 200 can also be fixedly connected in other ways, as long as the manifold 13 is fixed to the reagent injection device 200. The manifold 13 is connected to the manifold 10 and multiple delivery lines 20, allowing the multiple delivery lines 20 and the manifold 10 to converge at the manifold 13. A manifold cavity 14 can be formed within the manifold 13, which is connected to the manifold 10 and the multiple delivery lines 20. In the context of radiopharmaceutical injection, the reagents in the multiple delivery lines 20 can flow sequentially into the manifold cavity 14 and then into the manifold 10. Specifically, before drug injection, air in the tubing is purged by delivering saline solution. After injection, saline solution is used again to flush the manifold 10, pushing any residual medication into the patient's body. This makes the reagent delivery process more stable and safe, the drug dosage more precise, and avoids the health risks of toxic or radioactive reagents to staff. Furthermore, in scenarios involving mixed drug administration, reagents from multiple delivery lines 20 can flow into the manifold 14 for mixing before flowing back into the manifold 10, thus achieving reagent mixing.

[0109] According to some embodiments of the present invention, such as Figure 5 As shown, the shielding box 301 may have a top cover 51, which is the top wall of the first shielding cavity 302. The top cover 51 is rotatably or slidably disposed on the shielding box 301 to open or close the first shielding cavity 302.

[0110] The top cover 51 is rotatably mounted on the shielding box 301, or the top cover 51 is slidably mounted on the shielding box 301. This application uses the example of the top cover 51 being slidably mounted on the shielding box 301 for illustration. For example, the top cover 51 and the shielding box 301 can be connected by a slide rail, or the top cover 51 and the shielding box 301 can be connected by a sliding buckle. However, this utility model is not limited to these methods. The top cover 51 and the shielding box 301 can also be slidably connected in other ways, as long as the top cover 51 is slidably mounted on the shielding box 301. This application uses the example of the top cover 51 and the shielding box 301 being connected by a slide rail for illustration.

[0111] By providing a sliding top cover 51 to the shielding enclosure 301, and connecting the top cover 51 to the shielding enclosure 301 via a slide rail, the first shielding cavity 302 can be opened or closed easily by the user. The slide rail connection means that the top cover 51 does not require additional space, nor does it require complex tools or excessive force when opening or closing the first shielding cavity 302, which not only improves convenience, but also makes the shielding enclosure 301 more compact when the first shielding cavity 302 is closed, facilitating the movement of the shielding enclosure 301.

[0112] According to some embodiments of the present invention, such as Figure 6 As shown, the automatic drug delivery device 300 may further include: a locking structure 52, which is disposed in the shielded housing 301 and is used to lock or unlock the top cover 51.

[0113] The locking structure 52 can be a mechanical latch, a slide rail locking motor structure, a locking screw, a locking block, or other structures. The locking structure 52 is located within the shielding housing 301. For example, the locking structure 52 and the shielding housing 301 can be fixedly connected by bolts or by welding. However, this invention is not limited to these methods; the locking structure 52 and the shielding housing 301 can also be fixedly connected by other means, as long as the locking structure 52 is located within the shielding housing 301. The locking structure 52 is used to lock or unlock the top cover 51. When it is necessary to open the top cover 51, the locking structure 52 can be unlocked to open the top cover 51. When it is not necessary to open the top cover 51, the locking structure 52 can be locked to close the top cover 51, preventing the top cover 51 from accidentally sliding open and causing a risk of impact, thereby improving the safety and reliability of the automatic drug delivery device 300.

[0114] According to some embodiments of the present invention, the locking structure 52 can be configured as a mechanical locking structure 52 or an electric locking structure 52.

[0115] The locking structure 52 can be constructed as a mechanical locking structure 52, such as a mechanical latch, locking screw, locking block, etc., or it can be constructed as an electric locking structure 52, such as an electromagnetic type, an electric rotary type, an electronic induction type, etc. The mechanical locking structure 52 has stable mechanical properties and high reliability, and its structure is relatively simple and easy to maintain and repair. The electric locking structure 52 can be integrated with the control system to realize remote control and monitoring, and improve the overall automation level of the system. It can be reasonably selected according to the actual situation, as long as the locking structure 52 can be used to lock or unlock the top cover 51.

[0116] According to some embodiments of the present invention, such as Figure 1 As shown, the top cover 51 may have a first shielding cover 307, and the shielding box 301 is formed with an operation hole 308 communicating with the first shielding cavity 302. The first shielding cover 307 is used to open or close the operation hole 308.

[0117] The top cover 51 may have a first shielding cover 307. For example, the first shielding cover 307 and the shielding box 301 may be fixedly connected by bolts, or the first shielding cover 307 and the shielding box 301 may be fixedly connected by snap-fit. The first shielding cover 307 may be rotatably connected to the shielding box 301 by a pivot shaft. However, this utility model is not limited to this. The first shielding cover 307 and the shielding box 301 may also be fixedly connected by other means, as long as the shielding box 301 has the first shielding cover 307.

[0118] The shielding housing 301 may have an operating hole 308 communicating with the first shielding cavity 302. The first shielding cover 307 is used to open or close the operating hole 308. When the first shielding cover 307 is opened to open the operating hole 308, the shielding container 303 can be placed inside the first shielding cavity 302. When the first shielding cover 307 is closed to cover the operating hole 308, the first shielding cavity 302 is in a sealed state, which can play a shielding role and thus effectively protect the personal safety of staff and patients. Furthermore, when the first shielding cover 307 is opened to open the operating hole 308, the staff can reach into the first shielding cavity 302 through the operating hole 308 to perform related operations, such as: taking out the reagent bottle 30 from the shielding container 303 and placing it into the placement slot 306, changing the reagent delivery device 100, and assembling the reagent delivery device 100 into the reagent injection device 200 and the liquid dispensing device 304, etc. After the staff has completed the operation, the first shielding cover 307 closes the operating hole 308.

[0119] According to some embodiments of the present invention, such as Figure 1As shown, there can be multiple operation holes 308 and multiple first shielding covers 307, with each operation hole 308 and each first shielding cover 307 corresponding to the other.

[0120] The automatic drug delivery device 300 can have multiple operating holes 308 and first shielding covers 307. For example, it can have two, three, or four operating holes 308 and first shielding covers 307. However, this invention is not limited to this; the automatic drug delivery device 300 can also have other numbers of operating holes 308 and first shielding covers 307, as long as there are multiple operating holes 308 and first shielding covers 307. Multiple operating holes 308 and multiple first shielding covers 307 are arranged in a one-to-one correspondence so that the first shielding cover 307 can be used to open or close the corresponding operating hole 308. When the first shielding cover 307 is opened to open the operating hole 308, the shielding container 303 can be placed inside the first shielding cavity 302. The operator's hand can be inserted into the first shielding cavity 302 through the operating hole 308 to perform related operations. When the first shielding cover 307 is closed to cover the operating hole 308, the first shielding cavity 302 is sealed, further enhancing the shielding effect and effectively protecting the safety of operators and patients. Furthermore, by providing multiple operating holes 308, multiple hands can be simultaneously inserted into the first shielding cavity 302 to complete the preparation of the injection reagent, which helps to improve injection efficiency.

[0121] According to some embodiments of this utility model, the automatic drug delivery device 300 further includes: an activity detection device 309, which can be an activity meter. The activity detection device 309 can be used to measure the activity of the reagent before and after injection. In the pre-injection preparation work, the staff can use the activity detection device 309 to perform activity detection on the corresponding reagent bottle 30 and record the activity value of the reagent or drug in the corresponding reagent bottle 30 before injection. After the reagent or drug in the corresponding reagent bottle 30 is injected into the patient through the reagent delivery device 100, the staff can use the activity detection device 309 to perform activity detection on the reagent delivery device 100 and the reagent bottle 30 and record the activity value of the reagent or drug in the reagent delivery device 100 and the reagent bottle 30 after injection. The infusion dose is recorded by recording the difference in activity of the reagent or drug before and after injection. The measurement data are all stored in the automatic drug delivery device 300 for subsequent diagnostic use and can also accurately control the injection dose of the reagent or drug.

[0122] According to some embodiments of the present invention, such as Figure 2As shown, the top wall of the first shielding cavity 302 and the shielding box 301 can be rotatably connected. For example, the top wall (top cover 51) of the first shielding cavity 302 and the shielding box 301 can be connected by a hinge, or the top wall of the first shielding cavity 302 and the shielding box 301 can be connected by a hinge. However, this utility model is not limited to this. The top wall (top cover 51) of the first shielding cavity 302 and the shielding box 301 can also be connected in other ways, as long as the top wall (top cover 51) of the first shielding cavity 302 and the shielding box 301 can be rotatably connected. The top wall (top cover 51) of the first shielding cavity 302 can be provided with a handle 324. By pulling up the handle 324, the top wall of the first shielding cavity 302 can be opened, which makes it easier for maintenance personnel to inspect and repair the components inside the first shielding cavity 302, thereby reducing the maintenance difficulty of the automatic drug delivery device 300 and thus reducing the maintenance cost of the automatic drug delivery device 300. In addition, it is convenient to put the components into the first shielding cavity 302 and to take out the components from the first shielding cavity 302.

[0123] According to some embodiments of the present invention, such as Figure 2 As shown, the activity detection device 309 can be disposed in the first shielding cavity 302 or fixedly disposed in the first shielding cavity 302. The activity detection device 309 is used to house the reagent delivery device 100 and / or the corresponding reagent bottle 30.

[0124] The activity detection device 309 can be used to house the reagent delivery device 100, or it can be used to house the corresponding reagent bottle 30, or it can be used to house both the reagent delivery device 100 and the corresponding reagent bottle 30. This application will use the example of the activity detection device 309 being used to house both the reagent delivery device 100 and the corresponding reagent bottle 30 for illustration.

[0125] Furthermore, in the pre-injection preparation work, the staff can operate through the operation hole 308 of the first shielding cavity 302 to place the corresponding reagent bottle 30 into the activity detection device 309 for activity detection, and record the activity value of the reagent or drug in the corresponding reagent bottle 30 before injection. After the reagent or drug in the corresponding reagent bottle 30 is injected into the patient through the reagent delivery device 100, the staff can operate through the operation hole 308 of the first shielding cavity 302 to place the reagent delivery device 100 and the reagent bottle 30 into the activity detection device 309 for activity detection, and record the activity value of the reagent or drug in the reagent delivery device 100 and the reagent bottle 30 after injection. The infusion dose is recorded by recording the difference in activity of the reagent or drug before and after injection. All measurement data are stored in the automatic drug delivery device 300 for subsequent diagnostic use, and can also accurately control the injection dose of reagent or drug.

[0126] According to some embodiments of the present invention, such as Figure 2 As shown, the activity detection device 309 can be disposed within the first shielding cavity 302 or sunken and fixedly mounted in the first shielding cavity 302. This application uses the example of the activity detection device 309 being sunken and fixedly mounted in the first shielding cavity 302 for illustration. The activity detection device 309 has an open end, and the reagent delivery device 100 and / or the corresponding reagent bottle 30 for measuring the activity are placed into the open end of the activity detection device 309. The activity detection device 309 has an open end that communicates with the bottom wall of the first shielding cavity 302. For example, the bottom wall of the first shielding cavity 302 and the activity detection device 309 can be connected by welding, or the bottom wall of the first shielding cavity 302 and the activity detection device 309 can be fixedly connected by bolts. However, this utility model is not limited to these methods. The bottom wall of the first shielding cavity 302 and the activity detection device 309 can also be connected in other ways, as long as the bottom wall of the first shielding cavity 302 and the activity detection device 309 are fixedly connected to enable communication between the activity detection device 309 and the first shielding cavity 302. Therefore, operators can operate the activity detection device 309 through the operation hole 308 of the first shielding cavity 302, inserting the reagent delivery device 100 and / or the corresponding reagent bottle 30 through the open end of the activity detection device 309 to perform activity detection. As one embodiment of this application, the activity detection device 309 can be used to house the reagent delivery device 100; as another embodiment, the activity detection device 309 can be used to house the corresponding reagent bottle 30; as yet another embodiment, the activity detection device 309 can be used to house both the corresponding reagent bottle 30 and the reagent delivery device 100.

[0127] Furthermore, in the pre-injection preparation work, the staff can operate through the operation hole 308 of the first shielding cavity 302 to place the corresponding reagent bottle 30 into the activity detection device 309 for activity detection, and record the activity value of the reagent or drug in the corresponding reagent bottle 30 before injection. After the reagent or drug in the corresponding reagent bottle 30 is injected into the patient through the reagent delivery device 100, the staff can operate through the operation hole 308 of the first shielding cavity 302 to place the reagent delivery device 100 and the reagent bottle 30 into the activity detection device 309 for activity detection, and record the activity value of the reagent or drug in the reagent delivery device 100 and the reagent bottle 30 after injection. The infusion dose is recorded by recording the difference in activity of the reagent or drug before and after injection. All measurement data are stored in the automatic drug delivery device 300 for subsequent diagnostic use, and can also accurately control the injection dose of reagent or drug.

[0128] According to some embodiments of the present invention, such as Figure 6As shown, the automatic drug delivery device 300 may further include: a fixing frame 53, which is located inside the first shielding cavity 302 and fixed to the shielding box 301. The activity detection device 309 is used to place the reagent delivery device 100 and / or the corresponding reagent bottle 30. The fixing frame 53 covers the open end of the activity detection device 309. The fixing frame 53 is formed with a first through hole 55 corresponding to the open end of the activity detection device 309. The reagent delivery device 100 and / or the corresponding reagent bottle 30 are inserted into the activity detection device 309 or taken out from the activity detection device 309 through the first through hole 55. The fixing frame 53 can be made of metal materials, such as steel plate or iron plate. The fixing frame 53 is located inside the first shielding cavity 302 and is fixed to the shielding box 301. For example, the fixing frame 53 and the shielding box 301 can be connected by welding, or the fixing frame 53 and the shielding box 301 can be integrally formed. However, this utility model is not limited to this. The fixing frame 53 and the shielding box 301 can also be connected by other means, as long as the fixing frame 53 is fixed to the shielding box 301. The activity detection device 309 is used to house the reagent delivery device 100 and / or the corresponding reagent bottle 30. For example, the activity detection device 309 can house the reagent delivery device 100, or the corresponding reagent bottle 30, or both the reagent bottle 30 and the reagent delivery device 100. This application uses the example of the activity detection device 309 housing both the reagent bottle 30 and the reagent delivery device 100 for illustration. The first shielding cavity 302 can effectively shield external radiation and electromagnetic interference, ensuring a relatively stable detection environment within the activity detection device 309. This helps reduce errors caused by external factors and improves the accuracy of the detection results. It can also effectively shield the reagent delivery device 100 or the corresponding reagent bottle 30 used for activity detection within the activity detection device 309, reducing the radiation risk to workers. The mounting bracket 53 covers the open end of the activity detection device 309, and the mounting bracket 53 forms a first through hole 55 corresponding to the open end of the activity detection device 309. The reagent delivery device 100 and / or the corresponding reagent bottle 30 are inserted into or removed from the activity detection device 309 through the first through hole 55. The mounting bracket 53 may be provided with an opening and closing cover 54, which is used to open or close the first through hole 55. When the opening and closing cover 54 is open, it allows the operator to operate the activity detection device 309 through the first through hole 55. When the corresponding reagent bottle 30 is placed in the activity detection device 309 for activity detection, the opening and closing cover 54 can be closed so that the opening and closing cover 54 can cover the activity detection device 309, reduce the potential risk of radiation exposure, and protect the detection environment from external interference. This helps to maintain the environmental stability inside the activity detection device 309 and prevent external factors (such as dust, moisture, etc.) from interfering with the detection process.

[0129] The activity detection device 309 has an open top, which facilitates the insertion and removal of the reagent bottle 30, simplifies the detection process, helps improve work efficiency, and reduces errors caused by improper operation.

[0130] According to some embodiments of the present invention, such as Figure 1 As shown, the automatic drug delivery device 300 may further include: an activity display screen 310, which is disposed in the shielded enclosure 301 and is located outside or inside the shielded enclosure 301. The activity display screen 310 is communicatively connected to the activity detection device 309.

[0131] The activity level display screen 310 is disposed within and located within the shielding enclosure 301. For example, the activity level display screen 310 and the shielding enclosure 301 can be fixedly connected by bolts or by snap-fit ​​connection. However, this invention is not limited to these methods; the activity level display screen 310 and the shielding enclosure 301 can also be fixedly connected by other means, as long as the activity level display screen 310 is disposed within the shielding enclosure 301. Furthermore, the activity level display screen 310 can be located outside or inside the shielding enclosure 301. When the activity level display screen 310 is located outside the shielding enclosure 301, it facilitates the observation and recording of activity level values ​​by staff, thereby improving work efficiency. When the activity display screen 310 is placed inside the shielding enclosure 301, a transparent glass window can be provided at the position corresponding to the activity display screen 310 for displaying the activity display screen 310. This not only makes it easier for staff to observe and record the activity display values, but also prevents the activity display screen 310 from being scratched, thus avoiding blurring of the activity display screen 310, and also improves the appearance quality of the shielding enclosure 301.

[0132] The activity display screen 310 is communicatively connected to the activity detection device 309. For example, the activity display screen 310 and the activity detection device 309 can be connected via a wire harness or wirelessly. This enables the activity display screen 310 to receive and display the activity value detected by the activity detection device 309 for staff to record and use in subsequent diagnosis.

[0133] According to some embodiments of the present invention, such as Figure 2 As shown, the automatic drug delivery device 300 may further include: a waste shielding container 311, and the shielding box 301 may also form a second shielding cavity 312 that communicates with the first shielding cavity 302, with the waste shielding container 311 disposed in the second shielding cavity 312.

[0134] The automatic drug delivery device 300 may further include a waste shielding container 311, which can be used to collect the waste reagent delivery device 100 after injection. The shielding box 301 may also form a second shielding cavity 312 communicating with the first shielding cavity 302. The waste shielding container 311 is disposed in the second shielding cavity 312. For example, the waste shielding container 311 and the shielding box 301 can be fixedly connected by bolts, or the waste shielding container 311 and the shielding box 301 can be fixedly connected by snap-fit. However, this utility model is not limited to this. The waste shielding container 311 and the shielding box 301 can also be fixedly connected by other means, as long as the waste shielding container 311 is disposed in the second shielding cavity 312. Furthermore, the second shielding cavity 312 can be made of shielding material, such as lead, iron, or other shielding materials, so that the second shielding cavity 312 can have a shielding effect, thereby reducing the risk of radiation from residual reagents or drugs in the waste reagent delivery device 100 to workers.

[0135] According to some embodiments of the present invention, such as Figure 2 As shown, the automatic drug delivery device 300 may further include: a second shielding cover 313, the shielding box 301 having a communication port 314 connecting the first shielding cavity 302 and the second shielding cavity 312, and the second shielding cover 313 being used to open or close the communication port 314.

[0136] The automatic drug delivery device 300 may further include a second shielding cover 313. For example, the second shielding cover 313 and the shielding box 301 may be fixedly connected by bolts, or by snap-fit ​​connection, or the second shielding cover 313 and the shielding box 301 may be separately configured. However, this invention is not limited to these methods; the second shielding cover 313 and the shielding box 301 may also be fixedly connected by other means, as long as the automatic drug delivery device 300 includes a second shielding cover 313. This application uses the example of the second shielding cover 313 being rotatably connected to the shielding box 301 via a pivot shaft for illustration.

[0137] The shielding box 301 can form a connecting port 314 that connects the first shielding cavity 302 and the second shielding cavity 312. The second shielding cover 313 is used to open or close the connecting port 314. When the second shielding cover 313 is opened to open the connecting port 314, the staff can remove the reagent delivery device 100 through the operating hole 308 and place the waste reagent delivery device 100 into the waste shielding container 311 in the second shielding cavity 312 through the connecting port 314. When the second shielding cover 313 is closed to cover the connecting port 314, the second shielding cavity 312 is in a sealed state and can play a shielding role, thereby effectively protecting the personal safety of staff and patients.

[0138] According to some embodiments of the present invention, such as Figure 2 As shown, the second shielding cavity 312 is located below and adjacent to the first shielding cavity 302, meaning that the first shielding cavity 302 and the second shielding cavity 312 share a wall. The bottom wall of the first shielding cavity 302 is the top wall of the second shielding cavity 312. The bottom wall of the first shielding cavity 302 may have a connecting opening 314. The second shielding cover 313 is located inside the first shielding cavity 302, meaning that the second shielding cover 313 is connected to the bottom wall of the first shielding cavity 302. For example, the second shielding cover 313 and the bottom wall of the first shielding cavity 302 can be fixedly connected by bolts, or the second shielding cover 313 and the bottom wall of the first shielding cavity 302 can be fixedly connected by snap-fit. However, this utility model is not limited to this. The second shielding cover 313 and the bottom wall of the first shielding cavity 302 can also be fixedly connected by other means, as long as the second shielding cover 313 and the bottom wall of the first shielding cavity 302 are fixedly connected. The second shielding cover 313 can be rotatably connected to the bottom wall of the first shielding cavity 302 via a pivot shaft. This configuration allows staff to extend into the first shielding cavity 302 through the operating hole 308 to open the second shielding cover 313 and place the waste reagent delivery device 100 into the waste shielding container 311 inside the second shielding cavity 312. This facilitates the collection of medical waste by staff and avoids the risk of environmental exposure of the waste reagent delivery device 100, effectively protecting the personal safety of staff and patients.

[0139] According to some embodiments of the present invention, such as Figure 1 As shown, the shielding enclosure 301 may have a shielding door 315, and the second shielding cavity 312 is formed with a pick-up and put-out port 316. The shielding door 315 is used to open or close the pick-up and put-out port 316.

[0140] The shielding enclosure 301 may have a shielding door 315. For example, the shielding door 315 and the shielding enclosure 301 may be connected by a pivot pin, or the shielding door 315 and the shielding enclosure 301 may be connected by a hinge. However, this utility model is not limited to this. The shielding door 315 and the shielding enclosure 301 may also be connected by a hinge, as long as the shielding enclosure 301 has a shielding door 315.

[0141] The second shielding cavity 312 can have a pick-up and drop-off port 316. The shielding door 315 can be adapted to the pick-up and drop-off port 316 so that the shielding door 315 can block the pick-up and drop-off port 316. The shielding door 315 is used to open or close the pick-up and drop-off port 316. When the shielding door 315 is opened to open the pick-up and drop-off port 316, the waste shielding container 311 in the second shielding cavity 312 can be taken out and the medical waste such as the waste reagent delivery device 100 in the waste shielding container 311 can be transferred. After the medical waste is cleaned up and transferred, the waste shielding container 311 is put back into the second shielding cavity 312 and the shielding door 315 is closed to block the pick-up and drop-off port 316, so that the second shielding cavity 312 is in a closed state. This can effectively reduce the risk of radiation from the medical waste such as the waste reagent delivery device 100 in the second shielding cavity 312 to staff and patients, thereby effectively protecting the safety of staff and patients.

[0142] According to some embodiments of the present invention, such as Figure 1 and Figure 2 As shown, the shielding box 301 can form an observation port 317 corresponding to the first shielding cavity 302. There can be multiple observation ports 317. For example, the top wall and side wall of the first shielding cavity 302 can both form observation ports 317. The observation port 317 can be equipped with shielding glass, which can be lead glass. This facilitates operation and observation by staff, thereby improving the accuracy and efficiency of their work. It also ensures the shielding effect of the first shielding cavity 302, thus effectively protecting the safety of staff and patients.

[0143] According to some embodiments of the present invention, the automatic drug delivery device 300 further includes a shielding container 303, which is adapted to be placed in the first shielding cavity 302 and is used to store the corresponding reagent bottle 30.

[0144] The shielding container 303 can be a lead container to enable it to have shielding effectiveness and to shield radiation. The shielding container 303 is suitable for placement inside the first shielding cavity 302 and is used to store the corresponding reagent bottle 30. When the corresponding reagent bottle 30 contains radioactive drugs, the first shielding cavity 302 and the shielding container 303 can provide dual radiation shielding, thereby effectively protecting the personal safety of staff and patients.

[0145] According to some embodiments of this utility model, there can be multiple shielding canisters 303, for example, there can be two, three, four, or other numbers of shielding canisters 303. However, this utility model is not limited to this, and there can be other numbers of shielding canisters 303, as long as there are multiple shielding canisters 303. Multiple shielding canisters 303 are suitable for placement within the first shielding cavity 302. Each shielding canister 303 contains a reagent bottle 30 and corresponds to one patient. Staff can place multiple shielding canisters 303 containing reagent bottles 30 into the first shielding cavity 302 through the operation hole 308. This allows the automatic drug delivery device 300 to simultaneously hold multiple reagent bottles 30, thereby reducing the number of times staff need to retrieve reagents or drugs and improving the injection efficiency of the automatic drug delivery device 300.

[0146] It can be noted that the number of shielding tanks 303 can be reasonably set according to the actual situation, as long as it can meet the normal operation of the automatic drug delivery device 300.

[0147] According to some embodiments of the present invention, such as Figure 1 As shown, the automatic drug delivery device 300 may further include a controller 318, which is communicatively connected to the reagent injection device 200 and is configured to control the operation of the reagent injection device 200.

[0148] The automatic drug delivery device 300 may further include a controller 318, which is communicatively connected to the reagent injection device 200. For example, the controller 318 and the reagent injection device 200 can be connected via a wire harness or wirelessly; as long as the controller 318 and the reagent injection device 200 are communicatively connected, it is sufficient. The controller 318 is configured to control the operation of the reagent injection device 200. Thus, the operator can control the operation of the reagent injection device 200 by operating the controller 318, thereby reducing the operator's contact with the reagent bottle 30 and reducing the radiation hazard to the operator. For example, the operator can control the operation and power of the drive pump 23 of the reagent injection device 200 by operating the controller 318. As an embodiment of this application, the controller 318 can be a tablet computer, which can be held in hand or placed on the automatic drug delivery device 300 for operation. The controller 318 may include functions such as controlling the automatic drug delivery device 300 to perform self-tests, operation, setting parameters (including drug dosage and flow rate), and alarms; displaying relevant parameters, etc., thereby facilitating the automatic injection operation of the automatic drug delivery device 300.

[0149] According to some embodiments of the present invention, such as Figure 5As shown, a storage slot can be formed on the outside of the shielded enclosure 301. The storage slot is used to house the controller 318, which can be a tablet computer, smart display screen, etc. This makes the controller 318 more conspicuous and easy to reach, so that the staff can operate and control the controller 318. Furthermore, placing the controller 318 in the storage slot can reduce the risk of the controller 318 slipping or being lost during the movement of the automatic drug delivery device 300, thereby improving the safety of the automatic drug delivery device 300.

[0150] According to some embodiments of the present invention, such as Figure 5 As shown, the automatic drug delivery device 300 also includes an operating table 56, which is fixed to the shielded box 301 and located outside and on one side of the first shielded cavity 302. The top wall of the operating table 56 has a storage trough that is inclined along the height direction of the automatic drug delivery device 300.

[0151] The operating table 56 is fixed to the shielding box 301. For example, the operating table 56 and the shielding box 301 can be integrally formed, or the operating table 56 and the shielding box 301 can be fixedly connected by bolts. However, this utility model is not limited to this. The operating table 56 and the shielding box 301 can also be fixedly connected by other means, as long as the operating table 56 is fixed to the shielding box 301.

[0152] The operating table 56 is located outside and to one side of the first shielding cavity 302. Specifically, the operating table 56 can be located on the side of the first shielding cavity 302 near the activity display screen 310. The top wall of the operating table 56 has a storage slot that is inclined along the height direction of the automatic drug delivery device 300. The storage slot can be used to place the controller 318, so that the operator does not need to hold the controller 318, making it convenient for the operator to operate the controller 318. Furthermore, the height of the end wall of the storage slot near the edge of the shielding box 301 is lower than the height of the end wall of the storage slot near the first shielding cavity 302. With this arrangement, when the controller 318 is placed in the storage slot, the screen of the controller 318 is tilted towards the operator, so that the operator can see the information on the controller 318 more clearly, and can also easily reach the controller 318 while maintaining a comfortable posture, thereby reducing operator fatigue.

[0153] According to some embodiments of the present invention, the automatic drug delivery device 300 may further include an anti-loss structure, which is connected to both the controller 318 and the shielding box 301.

[0154] The anti-loss structure can be constructed as a chain, rope, etc. The anti-loss structure is connected to both the controller 318 and the shielding box 301, so that the controller 318 can be connected to the shielding box 301. During the movement of the shielding box 301, the anti-loss structure can effectively prevent the controller 318 from being damaged due to accidental drop, and can also prevent the controller 318 from falling from the shielding box 301 and being lost, thereby improving the service life of the controller 318 and reducing the operating cost of the automatic drug delivery device 300.

[0155] According to some embodiments of the present invention, such as Figure 5 As shown, the automatic drug delivery device 300 also includes an emergency stop button 319 and an operating table 56. The operating table 56 is fixed to the shielded box 301 and is located outside the first shielded cavity 302 and on one side of the first shielded cavity 302. The top wall of the operating table 56 is provided with an emergency stop button 319, which is configured to disconnect the automatic drug delivery device 300 from the power supply.

[0156] The automated drug delivery device 300 may further include an emergency stop button 319 and an operating panel 56. The emergency stop button 319 is configured to disconnect the automated drug delivery device 300 from the power supply. When reagent injection is completed or in case of an emergency, such as when the controller 318 malfunctions and cannot be controlled, disconnecting the power supply to the injection cart 300 via the emergency stop button 319 is a safety precaution. By triggering the emergency stop button 319, the operator can disconnect the automated drug delivery device 300 from the power supply, thereby stopping the reagent injection device 200 and reducing the risk of injection errors, thus improving the safety and reliability of the automated drug delivery device 300.

[0157] The operating table 56 is fixed to the shielding box 301. For example, the operating table 56 and the shielding box 301 can be integrally formed, or the operating table 56 and the shielding box 301 can be fixedly connected by bolts. However, this utility model is not limited to this. The operating table 56 and the shielding box 301 can also be fixedly connected by other means, as long as the operating table 56 is fixed to the shielding box 301.

[0158] The operating console 56 is located outside the first shielding cavity 302 and on one side of the first shielding cavity 302. The top wall of the operating console 56 is provided with an emergency stop button 319. This arrangement allows the emergency stop button 319 and the controller 318 to be integrated into the operating console 56. The height of the operating console 56 is adapted to the height of the human body, so as to facilitate the operation of the staff. This can improve the convenience and efficiency of the operation, thereby helping the staff to react quickly in emergency situations, reducing the possibility of accidents, and also reducing unnecessary physical movement and fatigue of the staff during operation.

[0159] According to some embodiments of the present invention, such as Figure 5 As shown, the automatic drug delivery device 300 also includes a power operation key 57 and an operating table 56. The operating table 56 is fixed to the shielded box 301 and is located outside the first shielded cavity 302 and on one side of the first shielded cavity 302. The top wall of the operating table 56 is provided with a power operation key 57, which is configured to control the automatic drug delivery device 300 to be powered on or off.

[0160] The operating table 56 is fixed to the shielding box 301. For example, the operating table 56 and the shielding box 301 can be integrally formed, or the operating table 56 and the shielding box 301 can be fixedly connected by bolts. However, this utility model is not limited to this. The operating table 56 and the shielding box 301 can also be fixedly connected by other means, as long as the operating table 56 is fixed to the shielding box 301.

[0161] Furthermore, the operating table 56 is located outside the first shielding cavity 302 and on one side of the first shielding cavity 302. The top wall of the operating table 56 is provided with a power operation button 57. This arrangement allows the power operation button 57 to be integrated into the operating table 56. The height of the operating table 56 is adapted to the height of the human body, so as to facilitate the operation of the staff. This allows the staff to quickly control the automatic drug delivery device 300 to be powered on or off, which can improve the convenience and efficiency of operation, and also reduce unnecessary physical movement and fatigue of the staff during operation.

[0162] According to some embodiments of the present invention, such as Figure 7 As shown, the automatic drug delivery device 300 may further include a disinfection device 58. The disinfection device 58 can be a physical disinfection device, a chemical disinfection device, such as an ultraviolet disinfection lamp or a sprayer. This application uses an ultraviolet disinfection lamp as an example for the disinfection device 58, which utilizes the bactericidal effect of ultraviolet light for disinfection. The disinfection device 58 is located within the first shielding cavity 302 and can disinfect the area within the first shielding cavity 302, thereby quickly killing bacteria, viruses, and other microorganisms within the first shielding cavity 302, maintaining a clean environment within the first shielding cavity 302, and thus providing further protection for patient safety. The disinfection device 58 can be selectively turned on or off, allowing for precise disinfection of specific areas or at specific times. This helps ensure disinfection effectiveness while reducing unnecessary disinfection operations and improving disinfection efficiency. By reasonably controlling the on / off time of the disinfection device 58, wear and tear and aging caused by overuse can be avoided, helping to extend the equipment's service life, reduce maintenance costs, and avoid unnecessary energy waste, thus helping to reduce overall energy consumption and improve energy utilization efficiency, in line with the concept of energy conservation and environmental protection.

[0163] According to some embodiments of the present invention, such as Figure 7 As shown, the disinfection device 58 is located on the side wall of the first shielding cavity 302. For example, the disinfection device 58 and the shielding box 301 can be fixedly connected by bolts, or the disinfection device 58 and the shielding box 301 can be fixedly connected by adhesive. However, this utility model is not limited to these methods. The disinfection device 58 and the shielding box 301 can also be fixedly connected by other methods, as long as the disinfection device 58 is located on the side wall of the first shielding cavity 302. Placing the disinfection device 58 on the side wall of the first shielding cavity 302 ensures that ultraviolet rays can evenly irradiate all corners of the first shielding cavity 302, avoiding disinfection dead spots caused by uneven ultraviolet ray distribution. The fixedly installed disinfection device 58 can provide more stable and continuous ultraviolet rays, thereby enhancing the disinfection effect. In addition, since the disinfection device 58 is relatively fixed in position, it also reduces the problem of insufficient or excessive disinfection that may be caused by ultraviolet ray movement. It is also easier to manage and monitor the disinfection device 58, monitor its working status and disinfection effect in real time, thereby ensuring the smooth progress of the disinfection work.

[0164] According to some embodiments of the present invention, such as Figure 5 As shown, the automatic drug delivery device 300 may further include a disinfection operation key 59. The disinfection operation key 59 is configured to disconnect or connect the disinfection device 58 to the power supply. When an operator presses the disinfection operation key 59, it connects the disinfection device 58 to the power supply, allowing the device to receive electrical energy and perform disinfection. When the operator presses the disinfection operation key 59 again, it disconnects the device from the power supply, preventing further power supply and stopping the disinfection process. This simple button operation allows operators to easily control the disinfection device 58 to turn on and off, meeting various disinfection needs.

[0165] Furthermore, when the automatic drug delivery device 300 is not in operation, the first shielding cavity 302 can be disinfected by the disinfection device 58, which can greatly reduce the generation of bacteria, so that the automatic drug delivery device 300 has a safe working environment, thereby effectively ensuring the safety of patients' medication.

[0166] According to some embodiments of the present invention, such as Figure 5 As shown, the automatic drug delivery device 300 also includes: an operating table 56, which is fixed to the shielded box 301 and located outside and on one side of the first shielded cavity 302. The top wall of the operating table 56 is provided with a disinfection operation button 59.

[0167] The operating table 56 is fixed to the shielding box 301 and is located outside the first shielding cavity 302 and on one side of the first shielding cavity 302. The top wall of the operating table 56 is provided with a disinfection operation button 59. This arrangement integrates the disinfection operation button 59 into the operating table 56. The height of the operating table 56 is adapted to the height of the human body, so as to facilitate the operation of the staff, improve the convenience and efficiency of the operation, and reduce unnecessary physical movement and fatigue of the staff during operation.

[0168] According to some embodiments of the present invention, such as Figure 5 As shown, the automatic drug delivery device 300 also includes a table 60, which is disposed on the outer surface of the shielded box 301 and is used to place objects.

[0169] The tabletop 60 is located on the outer surface of the shielding enclosure 301. For example, the tabletop 60 and the shielding enclosure 301 can be fixedly connected by bolts or by snap-fit. However, this invention is not limited to these methods; the tabletop 60 and the shielding enclosure 301 can also be fixedly connected by other means, as long as the tabletop 60 is located on the outer surface of the shielding enclosure 301. The tabletop 60 can be used to place objects, facilitating quick access and placement of items by staff, greatly improving the efficiency and convenience of staff in their work, and also providing a more comfortable and safer medical environment for patients. The size and load-bearing capacity of the tabletop 60 can be customized according to actual needs, and no specific limitations are made here.

[0170] According to some embodiments of the present invention, such as Figure 7 As shown, the tabletop 60 is movably disposed in the shielding box 301. The tabletop 60 has a first position and a second position. When the tabletop 60 is in the first position, the tabletop 60 is parallel to the horizontal plane. When the tabletop 60 is in the second position, the tabletop 60 is perpendicular to the horizontal plane.

[0171] The tabletop 60 is movably mounted on the shielding box 301. For example, the tabletop 60 and the shielding box 301 can be connected by a rotating shaft, or by a slide rail, or by a hinge. However, this utility model is not limited to these methods. The tabletop 60 and the shielding box 301 can be connected in other ways, as long as the tabletop 60 is movably mounted on the shielding box 301. The tabletop 60 is movably mounted on the shielding box 301, allowing it to move to a first position and a second position. This application uses the rotatable connection between the tabletop 60 and the shielding box 301 as an example for explanation. The tabletop 60 has a first position and a second position. When the tabletop 60 is in the first position, it is parallel to the horizontal plane. When the tabletop 60 is in the second position, it is perpendicular to the horizontal plane. The tabletop 60 can rotate from the first position to the second position, and it can also rotate from the second position to the first position. When it is necessary to use the tabletop 60 to place items, it can be rotated from the second position to the first position so that the tabletop 60 is parallel to the horizontal plane, thereby allowing items to be placed on the tabletop 60. When the table 60 is not needed, it can be rotated from the first position to the second position so that it is perpendicular to the horizontal plane. This allows the table 60 to be folded up, saving space or preventing it from bumping into the patient. This makes the use of the table 60 more flexible and adaptable to different needs, thereby improving the functionality of the automatic drug delivery device 300.

[0172] According to some embodiments of the present invention, such as Figure 7 As shown, the automatic drug delivery device 300 also includes a support structure 61, which is connected between the table 60 and the shielding box 301. When the table 60 is in the first position, the support structure 61 supports the table 60.

[0173] The support structure 61 connects the tabletop 60 and the shielding box 301. For example, the support structure 61 can be connected to the tabletop 60 and the shielding box 301 via a pin, a pivot, or other structure. However, this invention is not limited to this; the support structure 61 can also be connected to the tabletop 60 and the shielding box 301 in other ways, as long as the support structure 61 is connected between the tabletop 60 and the shielding box 301. When the tabletop 60 is in the first position, the support structure 61 supports the tabletop 60 so that the tabletop 60 is parallel to the horizontal plane, allowing items to be placed on the tabletop 60. The support structure 61 provides support to the tabletop 60, ensuring that the tabletop 60 is stably parallel to the horizontal plane, thereby improving the stability and reliability of the tabletop 60.

[0174] According to some embodiments of the present invention, such as Figure 7As shown, the tabletop 60 has a first end and a second end opposite to each other. The first end is rotatably disposed on the shielding box 301. A mounting beam 63 is formed on the lower surface of the tabletop 60. The mounting beam 63 forms a strip-shaped limiting hole 64. The strip-shaped limiting hole 64 extends along the arrangement direction of the first end and the second end. The support structure 61 includes a support rod 62. One end of the support rod 62 is rotatably connected to the shielding box 301. The other end of the support rod 62 is fitted into the strip-shaped limiting hole 64 and is movable along the strip-shaped limiting hole 64.

[0175] The tabletop 60 has a first end and a second end. The first end is rotatably disposed on the shielding box 301. For example, the first end of the tabletop 60 and the shielding box 301 can be rotatably connected by a pivot, or the first end of the tabletop 60 and the shielding box 301 can be rotatably connected by a hinge. However, this utility model is not limited to this. The first end of the tabletop 60 and the shielding box 301 can also be connected in other ways, as long as the first end of the tabletop 60 is rotatably disposed on the shielding box 301.

[0176] The lower surface of the tabletop 60 has a mounting beam 63. For example, the tabletop 60 and the mounting beam 63 can be fixedly connected by welding, or the tabletop 60 and the mounting beam 63 can be fixedly connected by bolts. However, this utility model is not limited to this. The tabletop 60 and the mounting beam 63 can also be fixedly connected by other means, as long as the lower surface of the tabletop 60 has a mounting beam 63.

[0177] The mounting beam 63 can form a strip-shaped limiting hole 64, which extends along the arrangement direction of the first end and the second end. The support structure 61 includes a support rod 62, one end of which is rotatably connected to the shielding box 301. For example, the support rod 62 and the shielding box 301 can be rotatably connected by a pivot, or the support rod 62 and the shielding box 301 can be rotatably connected by a hinge. However, this utility model is not limited to this. The support rod 62 and the shielding box 301 can also be rotatably connected in other ways, as long as one end of the support rod 62 is rotatably connected to the shielding box 301. The other end of the support rod 62 is fitted into the strip-shaped limiting hole 64 and is movable along the strip-shaped limiting hole 64. For example, the other end of the support rod 62 can be connected to a pin, which passes through the strip-shaped limiting hole 64 and can move within the strip-shaped limiting hole 64. Alternatively, the other end of the support rod 62 can be designed as a sliding head with a smooth surface, which is directly inserted into the strip-shaped limiting hole 64 and can move within the strip-shaped limiting hole 64. Or, the other end of the support rod 62 can be fitted with a roller, which is fitted into the strip-shaped limiting hole 64 and can roll within the strip-shaped limiting hole 64. However, this utility model is not limited to these, as long as the other end of the support rod 62 is fitted into the strip-shaped limiting hole 64 and is movable along the strip-shaped limiting hole 64.

[0178] Thus, by rotatably connecting one end of the support rod 62 to the shielding box 301, and by allowing the other end of the support rod 62 to move along the strip-shaped limiting hole 64, the other end of the support rod 62 can support the tabletop 60 to the first position, parallel to the horizontal plane. Then, by fixing the relative position of the support rod 62 and the mounting beam 63, the tabletop 60 can be reliably held in the first position, and items can be placed on the tabletop 60.

[0179] In another embodiment, such as Figure 8 and Figure 9 As shown, the support structure 61 can be a pivot structure. The support structure 61 connects the tabletop 60 and the shielding box 301. When the tabletop 60 is in the first position, the support structure 61 supports the tabletop 60, making it parallel to the horizontal plane. This allows items to be placed on the tabletop 60, and the support structure 61 provides support to ensure the tabletop 60 is stably parallel to the horizontal plane, thereby improving the stability and reliability of the tabletop 60. The support structure 61 can also be connected to the tabletop 60 and the shielding box 301 in other ways, as long as the support structure 61 is connected between the tabletop 60 and the shielding box 301. When the tabletop 60 is in the first position, the support structure 61 supports the tabletop 60, making it parallel to the horizontal plane. This allows items to be placed on the tabletop 60, and the support structure 61 provides support to ensure the tabletop 60 is stably parallel to the horizontal plane, thereby improving the stability and reliability of the tabletop 60. When the table 60 is rotated to the second position and is perpendicular to the horizontal plane, the support structure 61 does not need to provide support for the table 60. The table 60 is then folded up to save space or prevent the table 60 from bumping into the patient. This makes the use of the table 60 more flexible and adaptable to different needs, thereby further enhancing the functionality of the automatic drug delivery device 300.

[0180] According to some embodiments of the present invention, such as Figure 7 As shown, a second through hole 65 communicating with the first shielding cavity 302 is formed on the side wall of the first shielding cavity 302. The second through hole 65 can be located on the side wall of the first shielding cavity 302 near the table 60, and the reagent injection assembly 500 passes through the second through hole 65 so that the reagent injection assembly 500 can pass through the second through hole 65 and connect to the patient, thereby realizing the injection of the patient. In addition, this arrangement can facilitate the maintenance and replacement of the reagent injection assembly 500, reduce the risk of the reagent injection assembly 500 being blocked, and thus reduce the injection cost and improve the reliability of the automatic drug delivery device 300. It should be noted that the reagent delivery device 100 of the reagent injection assembly 500 passes through the second through hole 65.

[0181] As an example of this application, such as Figure 6As shown, a saline bag 66 can also be installed on the shielded box 301. The saline bag 66 can be hung on the shielded box 301 by a hanging rod, or it can be directly hung on the side wall of the shielded box 301. The saline bag 66 stores physiological saline, which can be quickly retrieved by staff when needed to provide timely fluid replenishment for patients. The convenient access to the saline bag 66 reduces the time that staff spend searching for and preparing the saline bag 66, thereby improving the efficiency of emergency treatment and further ensuring the safety of patients.

[0182] According to some embodiments of the present invention, such as Figure 1 As shown, the shielding housing 301 can be connected to casters 320. For example, the casters 320 and the shielding housing 301 can be connected by a pivot, or by a pin. However, this invention is not limited to these methods; the casters 320 and the shielding housing 301 can also be connected in other ways, as long as the shielding housing 301 is connected to casters 320. This arrangement facilitates the movement of the shielding housing 301, thereby reducing the time it takes for the automatic drug delivery device 300 to move to the patient's bedside, thus improving the injection efficiency of the automatic drug delivery device 300; it also reduces the number of times the patient needs to move, making injections more convenient for the patient.

[0183] According to some embodiments of the present invention, such as Figure 1 As shown, the shielding enclosure 301 can be equipped with a handle 321. For example, the handle 321 can be fixedly connected to the shielding enclosure 301 by welding, or the handle 321 can be fixedly connected to the shielding enclosure 301 by bolts. However, this utility model is not limited to these methods. The handle 321 can also be fixedly connected to the shielding enclosure 301 in other ways, as long as the shielding enclosure 301 is equipped with a handle 321. Workers can push and pull the shielding enclosure 301 using the handle 321, which facilitates the control of the movement trajectory of the shielding enclosure 301 and reduces the risk of the shielding enclosure 301 bumping into things.

[0184] According to some embodiments of the present invention, such as Figure 5As shown, the handle 321 may include a fixed section, a connecting section, and a gripping section. The connecting section connects the fixed section and the gripping section. There can be two fixed sections for fixed connection with the automatic drug delivery device 300. There can be two gripping sections for the operator to hold with both hands. The gripping section of the handle 321 may be cylindrical to better fit the contour of the operator's hand and provide a comfortable gripping experience. The connecting section may include a connecting section body and two first sub-connecting sections. The connecting section body may be constructed in a "U" shape. The corresponding first sub-connecting section is connected between the connecting section body and the corresponding gripping section, and the corresponding first sub-connecting section forms an angle with the connecting section body and the corresponding gripping section. The size of the angle can be reasonably set according to ergonomic principles to facilitate the operator to adjust the angle of their arm and wrist as needed, thereby enhancing the operator's ability to operate the automatic drug delivery device 300 and making the movement of the automatic drug delivery device 300 safer and more efficient. Furthermore, the gripping section of the handle 321 may be covered with anti-slip materials, such as rubber or silicone, to increase the stability and safety of the operator when holding the handle 321.

[0185] In addition, the handle 321 can be located on the side wall of the shielded box 301 near the operating table 56, so that the staff can monitor and control the controller 318 on the operating table 56 at any time while moving the shielded box 301 through the handle 321, thereby reducing the risk of accidents and improving the safety of the automatic drug delivery device 300.

[0186] According to some embodiments of the present invention, such as Figure 9 As shown, the handle 321 can be designed in a "U" shape. The handle 321 is arranged around the circumference of the automatic drug delivery device 300. The handle 321 includes a first section, a second section, and a third section. The second section is connected between the first section and the third section. The first section and the third section are parallel and spaced apart. The first section and the third section are respectively fixedly connected to the two side walls of the automatic drug delivery device 300. The second section is parallel and spaced apart from the side wall of the automatic drug delivery device 300, so that the operator can hold the second section of the handle 321 to push the automatic drug delivery device 300. This design not only conforms to the ergonomic principle, allowing the user to hold it in the most natural way, reducing hand fatigue and discomfort, but also makes the handle 321 more visually concise and occupies less space, making it suitable for occasions with limited space. It can also enhance the overall aesthetic design of the automatic drug delivery device 300.

[0187] According to some embodiments of the present invention, such as Figure 2As shown, the shielding box 301 may have a mounting cavity 322, which may or may not be constructed as a shielding cavity. The mounting cavity 322 may be located below the first shielding cavity 302 and the second shielding cavity 312. The mounting cavity 322 may contain a power supply and electrical components. The electrical components can realize the connection, control, and protection functions of the automatic drug delivery device 300 circuit. The power supply can provide power to the entire automatic drug delivery device 300. The power supply, electrical components, and controller 318 are all connected. Through the coordinated use of the power supply, electrical components, and controller 318, the controller 318 can control the various components of the automatic drug delivery device 300 to work together. Only the patient's treatment plan needs to be input to realize automated injection, which simplifies the injection operation steps. In addition, during the injection process, it can greatly reduce the contact between the staff and the reagents, thereby reducing the radiation hazards of the reagents to the staff and effectively protecting the personal safety of the staff and the patients.

[0188] According to some embodiments of the present invention, such as Figure 2 As shown, the exterior of the shielding enclosure 301 can also be equipped with a storage slot 323, which can be used to place items such as notebooks and controllers 318 (tablet computers) for staff to record work steps. The exterior of the shielding enclosure 301 can also be equipped with hooks 325, which can be used to hang some frequently used operating tools or equipment power cords, thereby avoiding staff having to go back and forth to retrieve tools and improving work efficiency.

[0189] According to some embodiments of the present invention, such as Figure 3 As shown, a plurality of fixing seats 203 are fixed on the outer surface of the reagent injection device 200, and the plurality of fixing seats 203 are respectively used to install the manifold 10 and the plurality of delivery lines 20.

[0190] The reagent injection device 200 may have multiple fixing seats 203 fixed on its outer surface. For example, two, three, four, or other numbers of fixing seats 203 may be fixed on the outer surface of the reagent injection device 200. However, this invention is not limited to this; other numbers of fixing seats 203 may also be fixed on the outer surface of the reagent injection device 200, as long as multiple fixing seats 203 are fixed on the outer surface of the reagent injection device 200. The multiple fixing seats 203 are used to install the manifold 10 and multiple delivery pipes 20, respectively. The fixing seats 203 may form snap-fit ​​interfaces. The manifold 10 may snap into the snap-fit ​​interface of the corresponding fixing seat 203, and the delivery pipe 20 may snap into the snap-fit ​​interface of the corresponding fixing seat 203. The manifold 10 may also be bonded to the corresponding fixing seat 203, and the delivery pipe 20 may also be bonded to the corresponding fixing seat 203. This arrangement can regulate the extension paths of the manifold 10 and the delivery pipe 20, thereby reducing the risk of the manifold 10 and the delivery pipe 20 moving or colliding, as well as the risk of the manifold 10 and the delivery pipe 20 getting tangled together. It can also reduce the risk of the manifold 10 and the delivery pipe 20 getting tangled with other components on the surface of the outer casing 202, which in turn helps to improve the safety and reliability of the reagent delivery by the manifold 10 and the delivery pipe 20.

[0191] The reagent delivery device 100 of this application can be used in radiopharmaceutical injection scenarios, or it can also be used in other mixed reagent scenarios, such as drug mixing scenarios, and can be connected to a reagent container to mix drugs.

[0192] According to some embodiments of the present invention, such as Figure 3 As shown, at least one of the manifold 10 and the plurality of delivery lines 20 is provided with a bubble detection element 41, which is fixed to the reagent injection device 200.

[0193] In this invention, at least one of the manifold 10 and the multiple delivery pipes 20 is equipped with a bubble detection element 41. For example, the manifold 10 or one of the delivery pipes 20 may be equipped with a bubble detection element 41. However, this invention is not limited to this; both the manifold 10 and the delivery pipes 20 may be equipped with a bubble detection element 41, as long as at least one of the manifold 10 and the multiple delivery pipes 20 is equipped with a bubble detection element 41. As one embodiment of this invention, both the manifold 10 and the multiple delivery pipes 20 are equipped with a bubble detection element 41. The bubble detection element 41 can be a bubble sensor. With this configuration, the presence of bubbles can be detected in both the manifold 10 and the multiple delivery pipes 20, allowing staff to remove bubbles in a timely manner and effectively preventing bubbles from entering the patient's body, thereby helping to ensure the patient's safety.

[0194] The bubble detection element 41 can be fixed to the reagent injection device 200. For example, the bubble detection element 41 and the reagent injection device 200 can be connected by a snap-fit ​​connection or by an adhesive connection. However, this utility model is not limited to these methods. The bubble detection element 41 and the reagent injection device 200 can also be connected in other ways, as long as the bubble detection element 41 is fixed to the reagent injection device 200. Therefore, fixing the bubble detection element 41 to the reagent injection device 200 can reduce the risk of the bubble detection element 41 moving around, so as to avoid the bubble detection element 41 moving around randomly and affecting the detection effect, thereby improving the safety and reliability of the bubble detection element 41.

[0195] According to some embodiments of the present invention, such as Figure 3 As shown, the manifold 10 is equipped with a flow detection element 40, which is fixed to the reagent injection device 200.

[0196] The manifold 10 may be equipped with a flow detection element 40, which can detect the flow rate of the drug in the manifold 10, accurately record the real-time measurement data, and facilitate subsequent diagnosis. Furthermore, the flow detection element 40, used in conjunction with the aforementioned bubble detection element 41, can further enhance the pipeline safety of the reagent delivery device 100, thereby further ensuring patient safety. The flow detection element 40 is fixed to the reagent injection device 200. For example, the flow detection element 40 and the reagent injection device 200 can be connected by a snap-fit ​​connection or by an adhesive connection. However, this invention is not limited to these methods; the flow detection element 40 and the reagent injection device 200 can also be connected in other ways, as long as the flow detection element 40 is fixed to the reagent injection device 200. Therefore, fixing the flow detection element 40 to the reagent injection device 200 can reduce the risk of the flow detection element 40 shifting, preventing it from affecting the detection effect and thus improving the safety and reliability of the flow detection element 40.

[0197] According to some embodiments of the present invention, such as Figure 3 As shown, the manifold 10 is equipped with an air filter 43.

[0198] The manifold 10 may be equipped with an air filter 43, which can filter microorganisms, particulate matter and bubbles in the infusion solution during the infusion process, thereby avoiding symptoms such as infection and allergies in patients, thus effectively ensuring patient safety and improving the safety and reliability of the reagent injection device 200.

[0199] The air filter 43 and the reagent manifold 10 can be integrated. The manifold 10 is fixedly connected to the reagent injection device 200, which can reduce the risk of the air filter 43 moving around and thus avoid the air filter 43 moving around and affecting the detection effect, thereby improving the safety and reliability of the air filter 43.

[0200] According to some embodiments of the present invention, such as Figure 9 and Figure 10 As shown, the automatic drug delivery device 300 may further include: a support base 68, which is fixed in the first shielding cavity 302, and the upper surface of the support base 68 is at least partially a mounting slope 681, and an air filter 43 is mounted on the mounting slope 681.

[0201] The bracket 68 is fixed within the first shielding cavity 302 for mounting the air filter 43. At least a portion of the upper surface of the bracket 68 is a mounting slope 681. For example, half or one-third of the upper surface of the bracket 68 may be a mounting slope 681, or the entire upper surface of the bracket 68 may be a mounting slope 681. The air filter 43 is mounted on the mounting slope 681, which not only allows for proper installation within a limited space, avoiding wasted space, but also improves airflow distribution within the air filter 43, enabling more even airflow and increasing its filtration efficiency while reducing dust and contaminant accumulation.

[0202] According to some embodiments of the present invention, such as Figure 9 As shown, the automatic drug delivery device 300 may further include: a fixing frame 53 located inside the first shielding cavity 302 and fixed to the shielding box 301, and a support base 68 fixed to the fixing frame 53.

[0203] The fixing frame 53 is located inside the first shielding cavity 302 and fixed to the shielding box 301. For example, the fixing frame 53 and the shielding box 301 can be connected by welding, or the fixing frame 53 and the shielding box 301 can be integrally formed. However, this utility model is not limited to this. The fixing frame 53 and the shielding box 301 can also be connected by other means, as long as the fixing frame 53 is fixed to the shielding box 301. The support base 68 is fixed to the fixing frame 53. For example, the support base 68 and the fixing frame 53 can be fixedly connected by welding, or the support base 68 and the fixing frame 53 can be integrally formed. However, this utility model is not limited to this. The support base 68 and the fixing frame 53 can also be fixedly connected by other means, as long as the support base 68 is fixed to the fixing frame 53.

[0204] Therefore, the fixing frame 53, located within the first shielding cavity 302 and fixed to the shielding box 301, serves as a support structure for the shielding box 301. It effectively distributes and bears the forces acting on the shielding box 301, reducing the risk of shaking or tilting during use. The bracket 68, fixed to the fixing frame 53, is used to install the air filter 43. The bracket 68 is tightly connected to the shielding box 301 via the fixing frame 53, ensuring the stable installation of the air filter 43 and its stable operation. This, in turn, improves the safety and reliability of the automatic drug delivery device 300.

[0205] According to some embodiments of the present invention, such as Figure 9 As shown, multiple fixing seats 203 can be fixed to the surface of the fixing frame 53. For example, two, three, four, or other numbers of fixing seats 203 can be fixed to the surface of the fixing frame 53. However, this utility model is not limited to this, and other numbers of fixing seats 203 can also be fixed to the surface of the fixing frame 53, as long as multiple fixing seats 203 are fixed to the surface of the fixing frame 53. The multiple fixing seats 203 are used to install the manifold 10 and multiple delivery pipes 20 respectively. The fixing seats 203 can form a snap-fit ​​interface. The manifold 10 can be snapped into the snap-fit ​​interface of the corresponding fixing seat 203, and the delivery pipe 20 can be snapped into the snap-fit ​​interface of the corresponding fixing seat 203. Alternatively, the manifold 10 can also be glued to the corresponding fixing seat 203, and the delivery pipe 20 can also be glued to the corresponding fixing seat 203. This arrangement can regulate the extension paths of the manifold 10 and the delivery pipe 20, thereby reducing the risk of the manifold 10 and the delivery pipe 20 moving or colliding, as well as the risk of the manifold 10 and the delivery pipe 20 getting tangled together. It can also reduce the risk of the manifold 10 and the delivery pipe 20 getting tangled with other components on the surface of the outer casing 202, which in turn helps to improve the safety and reliability of the reagent delivery by the manifold 10 and the delivery pipe 20.

[0206] According to some embodiments of the present invention, such as Figure 9 As shown, multiple drive pumps 23 can be fixed on the surface of the mounting bracket 53. Each delivery line 20 is matched with the corresponding drive pump 23 so that the reagent in the corresponding reagent bottle 30 flows into the manifold 10. The manifold 10 is adapted to be connected to the infusion set, so that the drug or liquid can be delivered to the patient through the infusion set.

[0207] According to some embodiments of the present invention, at least one of the manifold 10 and the plurality of delivery pipes 20 is constructed as a flexible hose. For example, the manifold 10 can be constructed as a flexible hose, or the plurality of delivery pipes 20 can all be constructed as flexible hoses. However, the present invention is not limited thereto. The manifold 10 and the plurality of delivery pipes 20 can all be constructed as flexible hoses, as long as at least one of the manifold 10 and the plurality of delivery pipes 20 is constructed as a flexible hose. As an embodiment of this utility model, the manifold 10 and the multiple delivery lines 20 can all be constructed as flexible tubes. The flexible tubes are made of non-toxic materials, which can ensure that no harm is caused to the patient during the infusion process. The flexible tube material has a certain degree of elasticity, which can adapt to pressure changes during the infusion process and withstand the flow pressure of the infusion fluid. The flexible tube is flexible and can pass through curves and bends, which facilitates operation and adjustment during the infusion process. It also facilitates the connection between the delivery line 20 and the reagent bottle 30 and the manifold 10 and the infusion device, thereby delivering the reagent to the patient's body. Therefore, by constructing the manifold 10 and the multiple delivery lines 20 as flexible tubes, the safety and reliability of the infusion process can be effectively guaranteed, which is conducive to ensuring the safety of the patient.

[0208] According to some embodiments of the present invention, such as Figure 3 As shown, the reagent injection assembly 500 may further include: a liquid dispensing device 304, both the liquid dispensing device 304 and the reagent delivery device 100 are disposed in the first shielding cavity 302, the liquid dispensing device 304 is used to place the corresponding reagent bottle 30, and the liquid dispensing device 304 cooperates with the reagent delivery device 100 to drive the reagent delivery device 100 to insert or pull out the corresponding reagent bottle 30.

[0209] The liquid collection device 304 and the reagent delivery device 100 are both located within the first shielding cavity 302. For example, the liquid collection device 304, the reagent delivery device 100, and the movable housing 301 can be connected by snap-fit ​​or by bolts. However, this invention is not limited to these methods. The liquid collection device 304, the reagent delivery device 100, and the movable housing 301 can also be connected in other ways, as long as the liquid collection device 304 and the reagent delivery device 100 are both located within the first shielding cavity 302. This design allows the first shielding cavity 302 to shield the liquid dispensing device 304 and the reagent delivery device 100, thereby reducing the radiation hazards to workers from the reagents or drugs delivered in the reagent delivery device 100. It also allows the first shielding cavity 302 to cover and protect the liquid dispensing device 304 and the reagent delivery device 100, thereby reducing the risk of the liquid dispensing device 304 and the reagent delivery device 100 being collided or scratched by external objects, and thus extending the service life of the mobile injection cart 300.

[0210] The liquid dispensing device 304 is used to place the corresponding reagent bottle 30, and the liquid dispensing device 304 cooperates with the reagent delivery device 100 to drive the reagent delivery device 100 to insert or remove the corresponding reagent bottle 30. When the liquid dispensing device 304 cooperates with the reagent delivery device 100 to drive the reagent delivery device 100 to insert the corresponding reagent bottle 30, the reagent delivery device 100 can take the reagent in the corresponding reagent bottle 30. When the reagent in the corresponding reagent bottle 30 is exhausted or the reagent delivery device 100 needs to be replaced, the liquid dispensing device 304 cooperates with the reagent delivery device 100 to drive the reagent delivery device 100 to remove the corresponding reagent bottle 30, thereby enabling the replacement of the reagent bottle 30 or the reagent delivery device 100. This avoids the need for workers to manually connect the reagent delivery device 100 to the corresponding reagent bottle 30, thereby reducing the radiation hazard to workers from the reagent in the reagent bottle 30.

[0211] According to some embodiments of the present invention, such as Figure 3 As shown, the reagent delivery device 100 may have a needle 42, and the liquid dispensing device 304 has a moving part 305 and a placement groove 306. The moving part 305 and the placement groove 306 are opposite to each other and spaced apart. The placement groove 306 is used to store the corresponding reagent bottle 30. The needle 42 is detachably mounted on the moving part 305. The moving part 305 moves toward or away from the placement groove 306 to drive the needle 42 to insert or pull out the corresponding reagent bottle 30.

[0212] The reagent delivery device 100 may have a needle 42. Inserting the needle 42 into the corresponding reagent bottle 30 connects the reagent delivery device 100 and the reagent bottle 30, thereby enabling the retrieval of the drug from the reagent bottle 30. The liquid dispensing device 304 may have a moving part 305 and a placement groove 306. The moving part 305 and the placement groove 306 are opposite to and spaced apart. The placement groove 306 is used to store the corresponding reagent bottle 30. The needle 42 is detachably assembled to the moving part 305. For example, the needle 42 and the moving part 305 can be assembled by snap-fit ​​or by insertion. However, this invention is not limited to these methods. The needle 42 and the moving part 305 can also be assembled in other ways, as long as the needle 42 is detachably assembled to the moving part 305. The liquid dispensing device 304 may have a drive unit, which may be a drive motor. The drive unit is communicatively connected to the controller 318. The controller 318 controls the drive unit to drive the moving part 305 to move toward or away from the placement tank 306, thereby driving the inserter 42 to insert into or remove the corresponding reagent bottle 30. When the liquid dispensing device 304 cooperates with the reagent delivery device 100 to drive the inserter 42 to insert into the corresponding reagent bottle 30, the reagent delivery device 100 can dispense the reagent in the corresponding reagent bottle 30. When the reagent in the corresponding reagent bottle 30 is exhausted or needs to be replaced... When the reagent delivery device 100 is in use, the liquid dispensing device 304, in conjunction with the reagent delivery device 100, can drive the needle 42 to pull out the corresponding reagent bottle 30, thereby enabling the replacement of the reagent bottle 30 and the reagent delivery device 100. This allows the automatic drug delivery device 300 to inject different drugs into different patients, or to replace only the reagent delivery device 100, thereby enabling the automatic drug delivery device 300 to inject the same drug into different patients. This reduces the number of times staff need to retrieve the drug and improves the injection efficiency of the automatic drug delivery device 300.

[0213] According to some embodiments of the present invention, such as Figure 9 As shown, the controller 318 can communicate with the liquid dispensing device 304, and the controller 318 is configured to control the operation of the liquid dispensing device 304.

[0214] The controller 318 and the liquid dispensing device 304 can be connected via a wire harness or wirelessly, as long as they are connected. The controller 318 is configured to control the operation of the liquid dispensing device 304 and the reagent injection device 200.

[0215] Therefore, by operating the controller 318, staff can control the operation of the liquid dispensing device 304 and the reagent injection device 200, thereby reducing staff contact with the reagent bottle 30 and thus reducing the radiation hazard to staff. For example, staff can control the liquid dispensing device 304 to insert or remove the needle 42 from the reagent bottle 30, and can also control the operation and power of the drive pump 23 of the reagent injection device 200.

[0216] According to some embodiments of the present invention, such as Figure 9 As shown, the automatic drug delivery device 300 further includes: a fixing frame 53, which is located in the first shielding cavity 302 and fixed to the shielding box 301. At least one of the liquid dispensing device 304, the reagent injection device 200 and the reagent delivery device 100 is partially fixedly assembled to the fixing frame 53.

[0217] The fixing frame 53 is located inside the first shielding cavity 302 and is fixed to the shielding box 301. For example, the fixing frame 53 and the shielding box 301 can be connected by welding, or the fixing frame 53 and the shielding box 301 can be integrally formed. However, this utility model is not limited to this. The fixing frame 53 and the shielding box 301 can also be connected by other means, as long as the fixing frame 53 is fixed to the shielding box 301.

[0218] At least one of the liquid dispensing device 304, reagent injection device 200, and reagent delivery device 100 is partially fixedly mounted on the mounting frame 53. For example, a portion of the liquid dispensing device 304 is fixedly mounted on the mounting frame 53, or a portion of the reagent injection device 200 is fixedly mounted on the mounting frame 53, or a portion of the reagent delivery device 100 is fixedly mounted on the mounting frame 53, or all of the liquid dispensing device 304, reagent injection device 200, and reagent delivery device 100 are partially fixedly mounted on the mounting frame 53, or portions of two of the liquid dispensing device 304, reagent injection device 200, and reagent delivery device 100 are partially fixedly mounted on the mounting frame 53.

[0219] This application uses the example of a liquid dispensing device 304, a reagent injection device 200, and a reagent delivery device 100 all being partially fixedly mounted on a mounting frame 53. This allows the mounting frame 53 to fix and support the liquid dispensing device 304, the reagent injection device 200, and the reagent delivery device 100, effectively reducing displacement or shaking of these devices during operation of the automatic drug delivery device 300 due to vibration, impact, or other external factors. This ensures the normal operation and accuracy of the automatic drug delivery device 300. The design of the mounting frame 53 allows for reasonable planning of the layout of the liquid dispensing device 304, the reagent injection device 200, and the reagent delivery device 100. Through precise calculation and adjustment, these devices can be installed in optimal positions to achieve the best workflow and efficiency. This not only reduces interference and conflict between devices but also improves the comfort and work efficiency of the staff.

[0220] Furthermore, the mounting bracket 52 is assembled with the liquid dispensing device 304, and the structural components of the liquid dispensing device 304 are mounted on the mounting bracket 52. This optimizes the housing of the liquid dispensing device 304, for example, by reducing its volume or eliminating the housing altogether. The mounting bracket 52 is also assembled with the reagent injection device 200, and the structural components of the reagent injection device 200 are mounted on the mounting bracket 52. For example, the drive pump 23 (specifically a peristaltic pump in this embodiment) can be directly fixed on the mounting bracket 52, eliminating the housing of the reagent injection device 200. Finally, the mounting bracket 52 is also assembled with the reagent delivery device 100, and the structural components of the reagent delivery device 100 are mounted on the mounting bracket 52. This eliminates the housing of the reagent delivery device 100, simplifying the structure of the automatic drug delivery device 300 and reducing its manufacturing cost.

[0221] According to some embodiments of the present invention, such as Figure 8 As shown, the automatic drug delivery device 300 may further include an alarm device 69, which is used to issue alarm information.

[0222] The alarm device 69 can be configured as a visual alarm, an auditory alarm, or other similar device. This application uses an alarm device 69 including an LED indicator and a buzzer as an example for explanation. The alarm device 69 can illuminate in red or other conspicuous colors and emit a loud sound when an alarm is triggered, thus ensuring that the alarm device 69 alerts the staff. The alarm device 69 can be configured to issue an alarm message when the top cover 51 accidentally opens the shielding cavity 302. Specifically, when the automatic drug delivery device 300 is in injection mode, the alarm device 69 is configured to issue an alarm message when the top cover 51 accidentally opens the shielding cavity 302, allowing the staff to immediately close the shielding cavity 302 upon accidental opening. This prevents the radioactive drug inside the shielding cavity 302 from being exposed to the patient and staff, reducing radiation risk and improving the safety of the automatic drug delivery device 300 when injecting drugs into patients.

[0223] In the description of this specification, the references to terms such as "one embodiment," "some embodiments," "illustrative embodiment," "example," "specific example," or "some examples," etc., indicate that a specific feature, structure, material, or characteristic described in connection with that embodiment or example is included in at least one embodiment or example of the present invention. In this specification, the illustrative expressions of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in one or more embodiments or examples.

[0224] Although embodiments of the present invention have been shown and described, those skilled in the art will understand that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the present invention, the scope of which is defined by the claims and their equivalents.

Claims

1. An automatic drug delivery device, characterized in that, include: A shielding enclosure, wherein the shielding enclosure forms a first shielding cavity; A reagent injection assembly, at least a portion of which is disposed within the first shielding cavity, is adapted to be connected to a reagent bottle and an infusion device, is used to connect the reagent bottle and the infusion device, and is also used to drive the reagent in the reagent bottle to flow along the reagent injection assembly.

2. The automatic drug delivery device according to claim 1, characterized in that, The shielding enclosure is movable.

3. The automatic drug delivery device according to claim 1, characterized in that, The infusion device is an indwelling needle or an intravenous infusion needle.

4. The automatic drug delivery device according to claim 1, characterized in that, The reagent injection assembly includes: A reagent delivery device, adapted to be connected to the reagent bottle and the infusion unit, the reagent delivery device being used to connect the reagent bottle and the infusion unit; A reagent injection device is provided inside the first shielded cavity. The reagent injection device cooperates with the reagent delivery device to drive the reagent in the reagent bottle to flow along the reagent delivery device.

5. The automatic drug delivery device according to claim 4, characterized in that, The reagent injection device is equipped with multiple drive pumps, and the reagent delivery device includes a manifold and multiple delivery lines. Each of the multiple delivery lines is adapted to be connected to a corresponding reagent bottle. The manifold is connected to the multiple delivery lines so that the delivery lines connect the manifold and the corresponding reagent bottle. Each delivery line cooperates with the corresponding drive pump so that the reagent in the corresponding reagent bottle flows into the manifold or another delivery line. The manifold is adapted to be connected to the infusion fitting.

6. The automatic drug delivery device according to claim 5, characterized in that, The reagent delivery device further includes: a manifold block, wherein a manifold cavity is formed within the manifold block, the manifold block is connected to the manifold pipeline and the plurality of delivery pipelines, the manifold cavity is connected to the manifold pipeline and the plurality of delivery pipelines, and the manifold block is fixed to the reagent injection device.

7. The automatic drug delivery device according to claim 1, characterized in that, The shielding enclosure has a top cover, which is the top wall of the first shielding cavity. The top cover is rotatably or slidably disposed on the shielding enclosure to open or close the first shielding cavity.

8. The automatic drug delivery device according to claim 7, characterized in that, Also includes: A locking structure is provided in the shielding enclosure and is used to lock or unlock the top cover.

9. The automatic drug delivery device according to claim 8, characterized in that, The locking structure is constructed as a mechanical locking structure or an electric locking structure.

10. The automatic drug delivery device according to claim 7, characterized in that, The top cover has a first shielding cover, and the shielding box has an operating hole that communicates with the first shielding cavity. The first shielding cover is used to open or close the operating hole.

11. The automatic drug delivery device according to claim 10, characterized in that, There are multiple operating holes and multiple first shielding covers, and each of the multiple operating holes and multiple first shielding covers corresponds to one another.

12. The automatic drug delivery device according to claim 4, characterized in that, Also includes: An activity detection device is used to measure the activity of a reagent before and after injection.

13. The automatic drug delivery device according to claim 12, characterized in that, The activity detection device is disposed within the first shielding cavity or is fixedly disposed within the first shielding cavity. The activity detection device is used to house the reagent delivery device and / or the corresponding reagent bottle.

14. The automatic drug delivery device according to claim 12, characterized in that, It also includes: a fixing frame, which is located inside the first shielding cavity and fixed to the shielding box. The activity detection device is used to place the reagent delivery device and / or the corresponding reagent bottle. The fixing frame covers the open end of the activity detection device and has a first through hole corresponding to the open end of the activity detection device. The reagent delivery device and / or the corresponding reagent bottle are inserted into the activity detection device or removed from the activity detection device through the first through hole.

15. The automatic drug delivery device according to claim 12, characterized in that, Also includes: An activity display screen is disposed in the shielded enclosure, and the activity display screen is located outside or inside the shielded enclosure. The activity display screen is communicatively connected to the activity detection device.

16. The automatic drug delivery device according to claim 1, characterized in that, Also includes: The waste shielding container has a second shielding cavity that communicates with the first shielding cavity, and the waste shielding container is disposed in the second shielding cavity.

17. The automatic drug delivery device according to claim 16, characterized in that, Also includes: The second shielding cover has a communication port connecting the first shielding cavity and the second shielding cavity, and the second shielding cover is used to open or close the communication port.

18. The automatic drug delivery device according to claim 17, characterized in that, The second shielding cavity is located below and adjacent to the first shielding cavity, the bottom wall of the first shielding cavity has the communication opening, and the second shielding cover is located inside the first shielding cavity.

19. The automatic drug delivery device according to claim 16, characterized in that, The shielding enclosure has a shielding door, and the second shielding cavity has a pick-and-place opening. The shielding door is used to open or close the pick-and-place opening.

20. The automatic drug delivery device according to claim 1, characterized in that, The shielding enclosure has an observation port corresponding to the first shielding cavity, and the observation port is provided with shielding glass.

21. The automatic drug delivery device according to any one of claims 1-20, characterized in that, Also includes: A shielding container, which is adapted to be placed inside the first shielding cavity, and is used to store corresponding reagent bottles.

22. The automatic drug delivery device according to claim 21, characterized in that, There are multiple shielding containers, and each of the multiple shielding containers is suitable for placement inside the first shielding cavity.

23. The automatic drug delivery device according to claim 4 or 5, characterized in that, Also includes: A controller is communicatively connected to the reagent injection device and is configured to control the operation of the reagent injection device.

24. The automatic drug delivery device according to claim 23, characterized in that, The exterior of the shielded enclosure has a storage compartment for housing the controller.

25. The automatic drug delivery device according to claim 24, characterized in that, Also includes: An operating table is fixed to the shielded enclosure and is located outside and on one side of the first shielded cavity. The top wall of the operating table has a storage slot that is inclined along the height direction of the automatic drug delivery device.

26. The automatic drug delivery device according to claim 23, characterized in that, Also includes: An anti-loss structure is provided, which is connected to both the controller and the shielded enclosure.

27. The automatic drug delivery device according to any one of claims 1-20, characterized in that, Also includes: An emergency stop button and an operating panel are provided. The operating panel is fixed to the shielded enclosure and is located outside the first shielded cavity and on one side of the first shielded cavity. The emergency stop button is provided on the top wall of the operating panel and is configured to disconnect the automatic drug delivery device from the power supply.

28. The automatic drug delivery device according to any one of claims 1-20, characterized in that, Also includes: The device includes a power control button and an operating panel. The operating panel is fixed to the shielded enclosure and is located outside and on one side of the first shielded cavity. The power control button is provided on the top wall of the operating panel and is configured to control the automatic drug delivery device to power on or off.

29. The automatic drug delivery device according to any one of claims 1-20, characterized in that, Also includes: A disinfection device is disposed within the first shielding cavity, and the disinfection device is selectively turned on or off.

30. The automatic drug delivery device according to claim 29, characterized in that, The disinfection device is fixed to the side wall of the first shielding cavity.

31. The automatic drug delivery device according to claim 29, characterized in that, Also includes: A disinfection operation key is configured to disconnect or connect the disinfection device to the power supply.

32. The automatic drug delivery device according to claim 31, characterized in that, Also includes: The operating table is fixed to the shielded box and is located outside the first shielded cavity and on one side of the first shielded cavity. The top wall of the operating table is provided with the disinfection operation button.

33. The automatic drug delivery device according to any one of claims 1-20, characterized in that, Also includes: A tabletop is provided on the outer surface of the shielding box and is used to place objects.

34. The automatic drug delivery device according to claim 33, characterized in that, The tabletop is movably disposed within the shielding enclosure. The tabletop has a first position and a second position. When the tabletop is in the first position, it is parallel to the horizontal plane. When the tabletop is in the second position, it is perpendicular to the horizontal plane.

35. The automatic drug delivery device according to claim 34, characterized in that, Also includes: A support structure is provided, which is connected between the tabletop and the shielding box. When the tabletop is in the first position, the support structure supports the tabletop.

36. The automatic drug delivery device according to claim 35, characterized in that, The tabletop has a first end and a second end opposite to each other. The first end is rotatably disposed on the shielding box. A mounting beam is formed on the lower surface of the tabletop. The mounting beam has a strip-shaped limiting hole. The strip-shaped limiting hole extends along the arrangement direction of the first end and the second end. The support structure includes a support rod. One end of the support rod is rotatably connected to the shielding box. The other end of the support rod is fitted into the strip-shaped limiting hole and is movable along the strip-shaped limiting hole.

37. The automatic drug delivery device according to any one of claims 1-20, characterized in that, The sidewall of the first shielding cavity is formed with a second through hole communicating with the first shielding cavity, and the reagent injection assembly passes through the second through hole.

38. The automatic drug delivery device according to any one of claims 1-20, characterized in that, The shielded enclosure is equipped with casters.

39. The automatic drug delivery device according to any one of claims 1-20, characterized in that, The shielding enclosure is equipped with a handle.

40. The automatic drug delivery device according to claim 5, characterized in that, The outer surface of the reagent injection device is fixed with a plurality of fixing seats, which are respectively used to install the manifold and the delivery pipeline.

41. The automatic drug delivery device according to claim 5, characterized in that, At least one of the manifold and the plurality of delivery lines is provided with a bubble detection element, which is fixed to the reagent injection device.

42. The automatic drug delivery device according to claim 5, characterized in that, The manifold is equipped with a flow detection device, which is fixed to the reagent injection device.

43. The automatic drug delivery device according to claim 5, characterized in that, The manifold is equipped with an air filter.

44. The automatic drug delivery device according to claim 43, characterized in that, Also includes: A bracket is fixedly disposed within the first shielding cavity, and at least a portion of the upper surface of the bracket is an inclined mounting surface, on which the air filter is mounted.

45. The automatic drug delivery device according to claim 44, characterized in that, Also includes: A fixing frame is located inside the first shielding cavity and fixed to the shielding box, and a support base is fixed to the fixing frame.

46. ​​The automatic drug delivery device according to claim 45, characterized in that, Also includes: A fixing base, wherein multiple fixing bases are fixed on the surface of the fixing frame, and the multiple fixing bases are respectively used to install the manifold and the multiple delivery pipes.

47. The automatic drug delivery device according to claim 5, characterized in that, At least one of the manifold and the plurality of delivery lines is constructed as a flexible hose.

48. The automatic drug delivery device according to claim 23, characterized in that, The reagent injection assembly also includes: The liquid extraction device and the reagent delivery device are both disposed within the first shielded cavity. The liquid extraction device is used to place the corresponding reagent bottle, and the liquid extraction device cooperates with the reagent delivery device to drive the reagent delivery device to insert or remove the corresponding reagent bottle.

49. The automatic drug delivery device according to claim 48, characterized in that, The reagent delivery device has a needle, and the liquid dispensing device has a moving part and a placement slot. The moving part and the placement slot are opposite to and spaced apart. The placement slot is used to store the corresponding reagent bottle. The needle is detachably mounted on the moving part. The moving part moves toward or away from the placement slot to drive the needle to insert into or pull out the corresponding reagent bottle.

50. The automatic drug delivery device according to claim 48, characterized in that, The controller is communicatively connected to the liquid collection device, and the controller is configured to control the operation of the liquid collection device.

51. The automatic drug delivery device according to claim 50, characterized in that, It also includes: a fixing frame, which is located inside the first shielding cavity and fixed to the shielding box, and a portion of at least one of the liquid extraction device, the reagent injection device and the reagent delivery device is fixedly assembled to the fixing frame.

52. The automatic drug delivery device according to any one of claims 1-20, characterized in that, Also includes: An alarm device, which is used to issue alarm information.

Images